THE CODEX: LABELLING OF FOOD DERIVED FROM
MODERN BIOTECHNOLOGY

(Spine title: The Codex: Labelling of Food Derived from Modern Biotechnology)
(Thesis format: Monograph)

By
Sowmya Latha Hemanahally Vishwanatha
Graduate Program in Law

A thesis submitted in partial fulfillment of the requirements
for the degree of Master of Laws

The School of Graduate and Postdoctoral Studies
Western University, London, Ontario, Canada

© Sowmya Latha Hemenally Vishwanatha (2012)

WESTERN UNIVERSITY
SCHOOL OF GRADUATE AND POSTDOCTORAL STUDIES
CERTIFICATE OF EXAMINATION
Supervisor

Examiners

______________________________
Professor Mark Perry

___________________________
Professor Sara Seck

Supervisory Committee

____________________________
Professor Margaret Ann Wilkinson

______________________________
Professor Sara Seck

______________________________
Professor Pratima Bansal

The thesis by
SOWMYA LATHA HEMANAHALLY VISHWANTHA
Title:
The Codex: Labelling of Foods Derived From Modern Biotechnology
is accepted in partial fulfilment of the
requirements for the degree of
Master of Laws

__________________________
Date

_______________________________
Chair of the Thesis Examination Board

ii

Abstract
The controversy surrounding labelling food derived from modern biotechnology plagued
the Codex Alimentarius Commission for nearly two decades. The Codex Alimentarius
Commission is a joint commission of the Food and Agricultural Organisation and the
World Health Organisation, which are specialised agencies of the United Nations. It was
set up in 1963 with a mandate to develop and recommend global food standards that
protect consumer health and promote international food trade. In 1993, the Codex
Alimentarius Commission took on the task of developing a global standard for labelling
food derived from modern biotechnology. With several demands for it to discontinue
work and an inability to arrive at a consensus, many questioned whether the Codex
Alimentarius Commission would be able to develop a standard for labelling food derived
from modern biotechnology. Despite all the uncertainties, the Codex Alimentarius
Commission finally adopted the “Compilation of Codex texts relevant to labelling of food
derived from modern biotechnology.” Amidst widespread publicity that the voice of the
consumers had finally been heard, the truth about the exact standards is opaque.

This thesis reviews the “Compilation of Codex texts relevant to labelling of food derived
from modern biotechnology” and how the Codex Alimentarius Commission arrived at
this recommendation. It identifies the ideological differences that led to a contentious
debate for nearly two decades and uncovers the possible implications of the panacea
adopted by the Codex Alimentarius Commission in July 2011. With the world being
divided on possible effects of production and consumption of foods derived from modern
biotechnology, the labelling requirements vary from country to country. The final
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Compilation of Codex texts is a set of recommendations that accepts different approaches
to labelling. The Compilation of Codex texts comprises of a set of ten guidelines that
need to be adopted in national labelling legislation or regulations.

This thesis also focuses and compares the labelling requirements in the European Union
and Canada. The voluntary model of labelling adopted in Canada permits corporations to
choose whether or not to label and some claim that this is a health and safety concern. In
the European Union there are more precise criteria for labelling. As the purpose of the
Codex Alimentarius Commission is to promote international food trade, this thesis
reviews the impact of the Compilation of Codex Texts on the above two alternative
approaches to labelling, and examines whether the Compilation of Codex texts can
promote international food trade.

Keywords: Labelling, Genetically Modified Food, Food Derived from Modern
Biotechnology, Codex Alimentarius Commission, Mandatory labelling, Voluntary
Labelling
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Chapter 1: Overview

“The labeling of genetically modified foods is an extremely complicated subject-one
that falls at the intersection of a complex scientific field and deeply held religious,
moral, and personal beliefs about what one puts into one's body. It is possible that there
is no right answer to the question whether foods should be labeled to indicate genetic
modification.”

Valery Federici1
1.1

Background

Biotechnology is a powerful tool that has developed smart solutions to eradicate several
production problems in the food and agriculture industry. It has the potential to help
achieve sustainable development of agriculture to meet the need of an expanding and
increasingly urbanized population. Although biotechnology has been well accepted in
some realms (for example, medicine), its use in the development of genetically modified
(GM) food has been at the centre of an extensive and emotionally charged debate.2 Some
of the benefits of use of biotechnology in agriculture include a reduction in pesticide use,
increased resistance to various fungal and bacterial infections, the ability to grow crops in
drought-prone and high metal-pollution areas, increased yield that has resulted in a
reduction of costs, and the production of vitamin- and iron-enriched food.

1

Valery Federici, “Genetically Modified Food And Informed Consumer Choice Comparing U.S. and E.U.
Labeling law”, online: (2010) 35 Brook. J. Int'l L. at 515 <http://heinonline.org>
2
FAO Statement on Biotechnology, March 2000, online: The Food and Agricultural Organisation
<www.fao.org/biotech/fao-statement-on-biotechnology/en/>
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Many, however, are skeptical about the benefits and are concerned with the long-term
effects of consuming GM food. There are concerns regarding the environmental effects,
such as the impact on bio-diversity, the creation of pesticide-resistant super weeds,3 and
the like that could arise due to extensive growth of genetically modified crops. Although
commercial use of genetically modified organisms has been around for some time, the
controversy of its use in food production still persists.

Labelling food derived from modern biotechnology (FDMB) has been promulgated as a
solution to address the concerns of consumers. Legislation on food labelling aims to
provide accurate information to consumers. Labels have to be truthful and should not
mislead consumers. The presence of GM ingredients cannot be identified without
laboratory testing, and hence the labelling of GM food has been suggested as a way to
bridge the knowledge gap between producers and consumers and increase consumer
awareness.

The globalization of the food industry has forced the debate over the use of biotechnology
beyond national frontiers. The Codex Alimentarius Commission (CAC) is a joint
commission of the World Health Organization (WHO) and the Food and Agricultural
Organization (FAO), both United Nations Specialized Agencies. CAC has been tasked
with establishing health and safety standards and regulating international food trade. The
ideological differences among policy makers in different countries have resulted in a wide

3

Supra note 1 at 525

2

and confusing spectrum of requirements for the use of modern biotechnology in
production and sale of food. CAC has been striving to establish a uniform set of
guidelines for almost two decades. On July 5, 2011, a compromise among the policy
makers was reached and a “Compilation of Codex Texts Relevant to Labelling of Foods
Derived from Modern Biotechnology”4 (Compilation) was adopted.

This thesis traces the negotiations at CAC and reviews the Compilation. An impact
analysis is undertaken to examine the possible implications of the Compilation in
reducing tensions and promoting free and fair food trade among countries with different
models of labelling.

1.2

Research Design

This thesis involves a doctrinal method of research in which a qualitative analysis of both
primary and secondary sources of information is undertaken to study the issues
surrounding the labelling of FDMB. This thesis is presented in this order: Chapter 1
provides an overview of the thesis; Chapter 2 is an introduction to the thesis topic;
Chapter 3 deals with CAC and the controversy over labelling of FDMB; Chapter 4 studies
possible impact of the Compilation on future requests for conciliation at WTO. Chapter 5
reviews and compares labelling regulation in Canada to the labelling legislation in the
European Union (EU) ; and Chapter 6 presents a summary of the issues arising from this
study of the Compilation.

4

Compilation of Codex Texts Relevant to Labelling of Foods Derived from Modern Biotechnology, 2011,
CAC/GL76-2011,
online:
Codex
Alimentarius
Commission
< http://www.codexalimentarius.org/standards/list-of-standards/en/>
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The details of the methodology adopted in this study vary depending on the chapter being
reviewed; however, an overview of the methodologies adopted herein is as follows:

Doctrinal: The first step in this research involved a review and analysis of primary sources
such as statues and guidelines both at the national and international level. The secondary
materials reviewed include journal articles and books to trace the history of biotechnology
as a science, the definition of concepts such as genetically modified organism (GMO) and
GM food, the purpose of food labelling, models of labelling legislation in different
countries, and issues in its implementation. Subsequently, my research involved a review
of the agendas and reports of the meetings of the Codex Committee on Food Labelling
(CCFL) related to the labelling of genetically modified food. Such research was primarily
undertaken to determine the nature of the labelling controversy at the CAC and to
understand the ideological differences amongst countries.

Descriptive:

The research involves a descriptive analysis of the Compilation, Canada’s

labelling policies, and the labelling legislation in the European Union and its
implementation in England to determine the exact rules applicable to labelling in the
international and national context. Primary materials include (a) the EU Food and Feed
Regulation 1829/2003,5 which creates a harmonized procedure for the scientific
assessment and authorization of genetically modified food and feed products, and (b) the

5

Regulation EC, Commission Regulation (EC) 1829/2003 of 22 September 2003 on genetically modified
food and feed [2003] OJ, L 268/1 at 13.

4

EU Traceability and Labelling regulation 1830/2003,6 which sets out the requirements for
a document audit trail to account for and identify approved GM products throughout the
marketing chain.. The labelling legislations in England are (a) Genetically Modified Food
(England) Regulations 2004,7 (b) the Genetically Modified Animal Feed (England)
Regulations 2004,8 and (c) the Genetically Modified Organisms (Traceability and
Labelling) (England) Regulations 2004.9 Labelling legislation in Canada includes (a) the
Food and Drug Act10 and its Regulations, (b) the Consumer Packaging and Labelling
Act11 and Regulations, and (c) “Voluntary Labelling and Advertising of Foods That Are
and Are Not Products of Genetic Engineering.”12

Some of the secondary sources reviewed to support my descriptive analysis for this thesis
are Genetically Modified Organisms: Why we need transparent system of regulation
(Mark Perry, 2010), Genetically Modified Food And Informed Consumer Choice
Comparing U.S. and E.U. Labeling law (Valery Federici, 2010), Labeling of genetically
modified foods: Legal and scientific issues (Goldman, Karen A, 2000), Regulating
biotechnology: comparing EU and US approaches (Patterson, Lee Ann & Josling, Tim,
2002), Labelling Genetically Modified food The Philosophical and Legal Debate, (Paul
Weirich, ed. Oxford University Press, 2007), Genetically Modified Food Labelling

6

Regulation EC, Commission Regulation (EC) 1830/2003 of 22 September 2003 on Traceability and
labelling of genetically modified organism [2003] OJ, L 268/24
7
Genetically Modified Food (England) Regulations, SI , 2004/2355
8
Genetically Modified Animal Feed (England) Regulations, SI, 2004/2334
9
Genetically Modified Organisms (Traceability and Labelling) (England) Regulations, SI, 2004/2412
10
Canada Food and Drugs Act, R.S.C. 1985, c.F-27, s 5 (1) and s 5.(2)
11
Consumer Packaging and Labelling Act, R.S.C. 1985, c.C-38,s 10
12
Canada, Canadian General Standards Board , National Standard of Canada on Voluntary Labelling And
Advertising of Foods That Are and Are Not Products of Genetic Engineering, (Canadian General Standards
Board 2004), <http://www.tpsgc-pwgsc.gc.ca/ongc-cgsb/programme-program/norms-standards>

5

Controversy: Ideological and Epistemic Crossovers (Mikael Klintman, 2002) and A
Survey of National Labelling Policies for GM Foods (Peter W.B. Phillips & Heather
McNeill, 2000).

Comparative: Subsequent to a review of the above policies and legislations, this research
focused on a comparison of the above policies and legislations. Such a comparison
provides a basis to understand and highlight possible areas of conflict. This analysis is
performed to examine the compliance of labelling policies within the requirements of the
Compilation.

Interdisciplinary: The research involves an interdisciplinary study of the impact of
international organizations, national legislations, and biotechnology on each other. As the
“Codex Alimentarius” or the Food Code is based on scientific analysis, this thesis
elaborates the role of science in the standards adopted by Codex. This thesis indicates the
relationships between science and international food standards and examines how such
food standards are interpreted and adopted by member countries in their national
legislation.

6

Chapter 2: Introduction
2.1

History and Meaning of Biotechnology

The term “biotechnology” was first used by Karl Ereky, a Hungarian engineer in the year
1919. He used the term to refer to a process that produced a product from raw materials
with living organisms.13 However, biotechnology can be traced to prehistoric times,
several ancient civilizations realized that microorganisms could be used to make useful
products. For example, yeast was used to make beer and wine. Rennet is an example of a
natural enzyme mixture from the stomach of calves or other domestic animals that has
been used in cheese making for centuries.14 Thus the use of microorganisms, which forms
the basis of biotechnology, is an ancient practice.

Further advances in science revealed that Ereky’s definition suggested only one aspect of
biotechnology, i.e., the use of a living organism. For many, however, the term
“biotechnology” is equated with the manipulation of genes. For a more specific technique
of gene manipulation the term “genetic engineering” is considered more appropriate.
Genetic engineering dates to the early 1970s. The first experiment to combine different
DNA molecules was performed in 1972 in the laboratory of Paul Berg (who shared the
1980 Nobel Prize in chemistry). The following year Stanley Cohen and Herbert Boyer
combined some viral DNA and bacterial DNA in a plasmid (which refers to a circular,
double-stranded unit of DNA that replicates within a cell. Plasmids are most often found

13

M.G. Fári & U. P. Kralovánszky, “The founding father of biotechnology: Károly (Karl) Ereky”, online:
(2006) 12:1 Int’l J of Hort’l Sci at 1 < http://www.agroinform.com/files/aktualis/pdf>
14
Enzymes used in Food Processing (16 August 2010), online: Health Canada <http://www.hc-sc.gc.ca/fnan/securit/addit/food_enzymes-eng.php>
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in bacteria and are used to transfer genes between cells15) to create the first recombinant
DNA organism.16 Thus Cohen and Boyer’s discovery opened the door for several
discoveries in the field of health sciences and agriculture.

Health Canada defines “biotechnology” as a term that covers a “broad range of scientific
activities used in many sectors, such as food, health and agriculture.” It elaborates further
that biotechnology involves the use of living organisms or parts of living organisms for
food production and the development of new and innovative products.17 The usage of the
term “living organisms or parts of living organisms” in this definition refers to the process
in which the genetic material of a particular living organism is altered by the introduction
of genetic material from another living organism. Such genetic material can be derived
from plants or animals and be inserted in either species. Sometimes, a bacterium carrying
desired traits is introduced into cells to change its genetic material to produce desired
consequences. Such a genetically modified plant or animal cell is referred to as a GMO–
derived from modern biotechnology.

A GMO according to the WHO is as follows:
“Genetically modified organisms (GMOs) can be defined as organisms in
which the genetic material (DNA) has been altered in a way that does not

15

Medical Dictionary, online: The Free Dictionary, sub verbo “Plasmid” <http://medicaldictionary.thefreedictionary.com/plasmid>
16
“Paul Berg, Herbert W. Boyer, and Stanley N. Cohen”, online, Chemical Heritage foundation
<http://www.chemheritage.org/discover/online-resources/chemistry-inhistory/themes/pharmaceuticals/preserving-health-with-biotechnology/berg-boyer-cohen.aspx>
17
“The world has witnessed extraordinary advances in science over the last few decades. Biotechnology one such area of growth - is a term covering a broad range of scientific activities used in many sectors, such
as food, health and agriculture. It involves the use of living organisms or parts of living organisms to
provide new methods of production and the making of new products.” –Science and Research,
Biotechnology (29 July 2008), online: Health Canada <http://www.hc-sc.gc.ca/sr-sr/biotech/index-eng.php>
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occur naturally. The technology is often called “modern biotechnology” or
“gene technology,” sometimes also “recombinant DNA technology” or
“genetic engineering.” It allows selected individual genes to be transferred
from one organism into another, also between non-related species. Such
methods are used to create GM plants – which are then used to grow GM food
crops.”18

Based on the above definitions it can be stated that GMO refers to organisms in which the
genetic material or the DNA composition has been altered in order to induce or remove
certain traits. This alteration may be achieved through the use of techniques that do not
occur naturally. Although genetic modification can be achieved even by conventional
breeding techniques, this research focuses on use of modern biotechnology in the
production of GM food. Some of the techniques used in modern biotechnology to alter
DNA composition, according to Voluntary Labelling and Advertising of Foods That Are
and Are Not Products of Genetic Engineering is paraphrased as follows19:

(a)

Recombinant techniques: This involves the use of biological vectors like
Plasmids and viruses to carry foreign genes into cells.

(b)

Microinjection: This involves injecting genetic material into the recipient cell.
This method is used where the cell is large enough, as many plant and animal
cells are; the injection can be done with a fine-tipped glass needle.

(c)

Electro and Chemical Poration: This involves creating pores or holes in the
cell membrane to permit entry of the new genes. This can be done by
immersing cells in chemical solutions or by subjecting cells to a weak electric

18

Food Safety, 20 Questions on Genetically Modified Food, 2011, online: World Health Organisation
<http://www.who.int/foodsafety/publications/biotech/20questions/en/index.html>
19
Supra note 12
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current.
(d)

Bioballistics: This involves using metals such as gold and silver to deliver
genetic material to the interior of the cell. Silver (much smaller than the
diameter of the target cell) is coated with genetic material and is loaded on a
shotgun to enter the cell. A perforated metal plate stops the shell cartridge, but
allows the metal to pass into the living cell. Once in the cell, the genetic
material is transported to the nucleus where it is incorporated among the host
genes.

2.2

Controversy over the Use of GMO in Food Production

Although GMOs have been used in the production of both food and drugs; it is their use
in the production of GM food that has generated extensive debate. Initially, the
introduction of the use of GMO in food production was well accepted; however, a
controversial study conducted in United Kingdom in the mid 1990s set off a storm. The
controversial study highlighted potential harmful effects on the stomach walls of rats due
to the consumption of genetically modified potatoes. It was reported in the media in 1996
and was later published in 1999.20 This led to widespread unrest about the safety of GM
food in Europe.21 The European food scare caused by the mad cow disease, although not
directly related to the use of GMO, further compounded the general public’s mistrust in

20

Dr. Ewen W.B. Stanley & Pusztai Arpad, “Effect of diets containing genetically modified potatoes
expressing Galanthus nivalis lectin on rat small intestine”, online: (1999) 354:9187 The Lancet
<http://www.thelancet.com/journals/lancet/article/PIIS0140673698058607>
21
Karen A. Goldman, “Labeling of genetically modified foods: Legal and scientific issues”, online: (2000)
12:3 Geo. Int'l Envtl. L. Rev <http://heinonline.org>
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science and scientists.22 This controversy culminated in the passing of the EU’s
Regulations on GM Food. Despite significant doubts about the validity of the study
conducted on rats, suspicion about the safety of FDMB spread across the globe. Several
governments, including in the US, re-emphasized the safety of genetically modified
food.23 It was contended that the genetically modified potatoes used in the study were not
commercially available and had not been approved for human consumption.24 Some of the
concerns regarding the use of genetically modified organisms relate to their safety in
foods, and some to their environmental safety (their impact on biodiversity and the
possibility that they might lead to the creation of “super weeds” or insects that are
resistant to pesticides).25

In addition to the environmental concerns stated above, there are social and psychological
concerns that need to be considered. Modern biotechnology has enabled the mixing of
genetic material of various species and between the plant and the animal kingdoms. This
ability to mix plant and animal genes has raised several religious and ethical concerns and
thereby has fuelled the controversy about the use of biotechnology in food production. 26

Scientists, the food industry, and policy makers in several countries regard the use of
biotechnology as the single most powerful tool available in the near future to address the

22

Lee Ann Patterson & Tim, Josling “Regulating biotechnology: comparing EU and US approaches”,
online: ( 2002) European Policy Papers 8, Archive of European Integration. < http://aei.pitt.edu/28/>
23
Supra note 21 at 720
24
Supra note 21 at 720
25
Supra note 21 at 719
26
Supra note 1 at 530
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problem of food shortage.27 The benefits often cited in support of the use of
biotechnology in food production are decreased pesticide use, increased yield, and better
quality and taste in crops. In addition, a wider variety of crops, the ability to grow
drought-resistant crops and increased nutritional value are also cited.28 Thus there are
strong arguments both in favour of and against the use of biotechnology in food
production. Concerns about the use of biotechnology in production of food have led to a
demand for the labelling of FDMB.29 Labelling is one of the methods by which
consumers can be informed about their food options and therefore choose the type of food
they want to consume. Although labelling has been suggested as a solution, it has also
contributed to the controversy.

2.3

Labelling of Genetically Modified Food

Food labels provide consumers with information about the product. There are various
components to food labels; they describe the nutritional composition of the food, the
package size, ingredients, manufacturing information, and the like. Thus these labels
provide consumers with information about the product and also impact consumer choice.
It is for this reason that governments have an interest in ensuring that the food label serve
to help consumers to make their selections wisely. 30 Labels are thus curial to trade and it
is because of this that each aspect of a label could generate extensive debate. All countries
have packaging and labelling legislation that aim to provide adequate and accurate

27

Supra note 1
Supra note 21 at 719
29
Supra note 21 at 720
30
Paul Weirich, ed, Labelling Genetically Modified food The Philosophical and Legal Debate, (Oxford,
New York, USA: Oxford University Press, 2007)
28
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information to consumers. Food labels should be truthful and not misleading. 31 The
underlying criteria for food labelling is summarized below32:
The primary objective of GM food labelling, and food labelling in general, is
to provide truthful information to consumers without misleading them. In
addition, food labels are generally designed to serve three purposes:
(a) to provide adequate and accurate information related to health and safety
concerns;
(b) to protect consumers and industries from fraudulent and deceptive
packaging and advertising practices; and
(c) to promote fair competition and product marketability.

Thus it is necessary for food labels on FDMB to provide adequate and accurate
information about this aspect of the product, prevent deception, and at the same time
promote fair competition. Even for those who agree on labelling as a possible solution,
fulfilling the above three purposes seems to be an insurmountable challenge. Resistance to
addressing this challenge may be attributed to the following: a) biotechnology involves
the use of complex scientific methodologies, making it difficult to summarize in a simple,
clear, and concise label, b) the difficulty of accurately determining genetically modified
organism content, c) the perception that product labelling affects product marketability.
The labelling of FDMB cannot therefore achieve the same amount of accuracy as other
types of labelling and it could obstruct fair trade as they can be misleading.

Some of the arguments against labelling are a) the cost of labelling and misleading labels
b) providing insufficient or inconsistent information and c) label verification issues (e.g.,

31

Janice Lee Albert, Labeling of genetically modified foods: Stakeholder perceptions of the food and drug
administrations public consultation processes and food industry reactions to the United States voluntary and
European Union mandatory policies, (Ph.D. diss., Tufts University Gerald J. and Dorothy R. Friedman
School of Nutrition Science and Policy, 2007), [unpublished]
32
Legislative Council Secretariat, Genetically Modified Food Labelling by Diana Wong (Hong Kong:
Research & Library Services Division 2003).
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negative labelling and the lack of accurate testing to determine claims).33 Other concerns
with labelling are that it is difficult to maintain the traceability of food’s origins, and, on a
larger scale, that it hampers innovation and scientific advancement. GM foods undergo
stringent tests and hence it is surmised that these products do not require additional
consumer-directed labelling. Many scientists, stakeholders in the food industry, and
policy makers in some countries do not consider it necessary to label GM food. Even
though some policy makers appreciate the need to protect the consumer’s right to know,
they have not been able to implement labelling. The dilemma of policy makers can be
summarized thus: “The debate is no longer about whether or not to develop a labelling
system for GM foods but rather how to develop a system that provides real consumer
choice without unduly interrupting international trade in agri-food products.”34

2.4

Models of Labelling

The very nature of the problem leads to a dual approach of labelling depending on
ideological differences. The two approaches to labelling of genetically modified food are
1) Mandatory Labelling and 2) Voluntary Labelling. It is necessary to understand the
benefits and disadvantages of each approach to be able to understand the labelling
controversy.

33

Mikael Klintman, “Genetically Modified Food Labelling Controversy: Ideological and Epistemic
Crossovers”, online: (2002) 32:1 Social Studies of Science at 76 <http://www.jstor.org/stable/3182978>
34
Peter W.B. Phillips & Heather McNeill, “A Survey of National Labelling Policies for GM Foods”, online:
(2000) 3:4 AgBioForum < http://www.agbioforum.org>

14

2.4 (a) Mandatory Labelling
Mandatory Labelling refers to a model of labelling where the legislation of a country
requires that products containing genetically modified ingredients be so labelled. In “A
Review of International Labeling Policies of Genetically Modified Food to Evaluate
India’s Proposed Rule” the authors state that mandatory labelling “requires food
companies (processors, retailers, and sometimes food producers) to display whether the
targeted product/ingredient contains or is derived from genetically engineered materials.”35
This definition captures the requirement of labelling for both products and process . It also
indicates that food processors, retailers, and food producers are responsible for labelling.
This ensures labelling throughout the chain of production and provides for documentation
and traceability. This documentation and traceability is essential for verification. The
practice of mandatory labelling attempts to bridge the knowledge asymmetry between the
producers and consumers. Mandatory labelling legislation around the world varies on
certain crucial factors, including “threshold levels,” “product or process labelling,” and
“exceptions to labelling”.

Threshold level refers to the maximum amount, expressed as a percentage of intended or
unintended genetically modified DNA or protein that is permitted. Anything above the
maximum amount would require labelling as containing genetically modified ingredients.
For example, the maximum permissible amount of genetically modified content in the EU
is 0.9%, in Australia and New Zealand it is 1%, in South Korea it is 3%, and in Japan it is

35
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5%.36 It is important to note that GM ingredients should be approved as safe by the
regulatory authorities and only approved genetically modified organisms are permitted to
be within the threshold level.37

Labelling requirements defined in mandatory labelling legislation vary with respect to
their application. Labelling legislation could apply to a product or process. In productbased labelling, the label is required if there are GM ingredients in the final product. In
process-based labelling, products that use GMOs during the production process are
labelled regardless of whether or GM content is detectable in the end product.38 China,
Brazil, and EU have process-based legislation. Most of the other countries, such as
Australia, Japan, and South Korea, have product-based labelling.39

Labelling legislation also varies with respect to what is exempt from labelling. For
example, in the EU cheese using GM enzymes, milk, eggs, and meat from animals fed
with genetically modified animal feed are exempt. In Australia and New Zealand,
vegetable oils, food additives, and food processing aids such as enzymes are exempt.40
The reasons for the exemptions are based on the detection techniques used by
governments to enforce labelling laws or in some cases the fact that there are no GM
ingredients in the products.
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The advantages of mandatory labelling include the fact that it respects the consumer’s
right to know; consumers who choose not to consume genetically modified food for
personal, religious, or ethical reasons can identify the same and make their informed
choice. Mandatory labelling also helps in post-market monitoring for potential unintended
effects. Several countries have mandated labelling, and many more are considering
adopting the policy. The disadvantages of the mandatory model involve a) a potential
increase in commodity prices due to cost of documentation, additional processing and
transportation, b) problems accurately tracing food origin, c) difficulty in determining
labelling thresholds, d) unfair competition between GM food and conventional food due
to the fact that GM food undergoes stringent testing prior to being approved for sale, e)
implementation difficulties such as faulty detection techniques, and f) difficulty in
communicating appropriate information regarding the use of animal genes in the
production of fruits and vegetables.41 Some other disadvantages include the problem of
“misleading labels,” i.e., when labels do not provide accurate information, and/or
deliberate adjustments to keep genetically modified content below allowed threshold to
avoid labelling.

2.4 (b) Voluntary Labelling
Countries that have actively supported the use GMOs in food have adopted a voluntary
labelling approach. In some countries, such as the US and Canada, labelling is mandatory
only if there is a health or safety issue with a food, for example, the presence of allergens
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(e.g., proteins from nuts) or some toxins that can raise safety concerns. Although the US
and Canada recognize consumer demand for labelling, the belief by policy makers and
scientists that genetically modified foods do not differ in any significant way from
conventional foods underlies the policy of voluntary labelling.42 GM food is generally
regarded as safe (GRAS). The countries advocating the voluntary approach to labelling
claim that GM foods undergo extensive long-term tests before they are approved and are
adequately tested to be regarded as safe. The inherent problem of the mandatory model of
labels not being able to adequately and accurately inform the consumers about GM
content has been cited as a reason for not labelling.

In the voluntary model of labelling, corporations are free to label their products as
containing/not containing GM ingredients. This is called positive or negative labelling,
respectively. Canada and the US are the largest proponents of the voluntary labelling
approach, and have adopted voluntary labelling guidelines. These guidelines aim to
achieve consistent and credible labelling systems.43 Guidelines are important to ensure
that the labels are accurate. The low implementation rates with the voluntary labelling
approach implies that corporations are not inclined or willing to positively label their
product. This may be due to the unfavourable consumer perception regarding genetically
modified food, their inability to provide accurate information on labels, documentation
costs, and the fact that not all corporations label and so voluntary labelling by some
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companies could lead to unfair competition.44 Negative labelling has to be verified, and
such labels might not receive approval as almost all crops are modified by plant
breeders.45

Some of the advantages of voluntary labelling include a) only consumers interested in
non-genetically modified food pay the increased cost, b) as genetically modified foods
pass extensive safety tests, conducted over several years, there is no need for further
labelling, c) providing increased choice to consumer, d) helping to advance
biotechnology, e) preventing unfair competition and f) labelling is at the companies’
discretion. The disadvantage with a voluntary model is that companies usually choose not
to label when provided the choice, hence violating the consumer’s moral right to know. It
also makes the study of unintended long-term effects difficult and may diminish the
market for traditional food products due to a lack of differentiation.46

2.5

Underlying Principles for Approval of GM Food

The approval and commercialization of GM food is based on two principles. A country’s
approach to labelling is also influenced by their application of these two principles.
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2.5 (a) Principle of Substantial Equivalence
The principle of “substantial equivalence” has been recognized by countries despite
differences in their approach to labelling. This principle has been adopted in safety
assessments for approving GM food for sale and consumption. The Organization for
Economic Co-operation and Development (OECD), in its handbook “Safety Evaluation of
Foods Derived from Modern Biotechnology” states substantial equivalence as a practical
approach to determine the safety of genetically modified food. It can be done by
comparing genetically modified food to its analogous conventional food.47

The application of the principle of substantial equivalence in the US for the approval of
genetically modified food based is summarized below48:
A determination of substantial equivalence requires analysis of GE foods
relative to comparable existing foods in terms of protein, fat, starch, amino
acid, vitamin, mineral, and phytonutrient composition. GE foods can be
designated substantially equivalent to their existing counterparts, substantially
equivalent except for certain defined differences (on which safety assessments
are then needed), or not substantially equivalent, meaning more safety testing
and further review are necessary.

The process indicates that the more different a GM food is, the more elaborate the testing
required. In Canada, all applicants must submit an initial application termed “Novel Food
Notification,” which would contain a complete description of the GM food along with the
process of development. Such an application is mandatory to be able to sell or advertise
novel foods in Canada. If the information in the application is deemed to be insufficient
after a review, then the applicant must submit a “Safety Assessment Data Package,”
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which includes detailed information about the safety of use of the product. All safety tests
and environmental analysis are undertaken prior to approval.49 Therefore safety analysis is
based on the applicant’s disclosure as well as an extensive review by Health Canada.50
The principle of substantial equivalence is also adopted in the EU to approve GM food. In
Canada and the US, subsequent to the approval, corporations are free to choose whether
or not to label; whereas, in the EU products containing GM food must be labelled,
depending on the threshold limit.

2.5 (b) Precautionary Principle
The Precautionary Principle is also applied by all countries in varying degrees. The aim of
the precautionary principle is to protect health and environment from risks.51 Various
interpretations of this principle have led to varied consequences. Cass R. Sunstein52
details the prevalent interpretations of the “Precautionary Principle” in the international
community. According to him, the weakest and most cautious interpretation of the
precautionary principle is that “a lack of decisive evidence of harm should not be a
ground for refusing to regulate.” This implies that if harm can be perceived then
governments should be cautious and take preventive measures. Other, stronger,
interpretations of the precautionary principle define the extent of damage, who should
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bear the burden of proof, and when preventive action should be taken. According to
Sunstein, the varied interpretations of the principle have led to a paralyzing effect on
development. Excessive interpretations have prevented “all courses of action including
inaction,” and regulation based on the precautionary principle deprives society of
significant “opportunity benefits”.53

Even though the use of the precautionary principle has been contested as defined above, it
has been followed in varying degrees in countries that actively support GM food and in
countries where support is not so favourable. The distrust among consumers in Europe has
led to the European Commission (EC) interpreting the principle within the context of risk
assessment of genetically modified foods and in the management of such risks. Thus, the
approval of genetically modified food in the EU requires safety assessment and
subsequent labelling based on the precautionary principle. The US, however, has applied
the precautionary principle only in assessing risks involved with the use of GM food.
Once a food has been assessed as safe then it does not require any further action.54

2.6

Codex Alimentarius Commission and Labelling

It was amid these different ideologies and approaches to labelling that the CAC was given
the mandate to compile a set of guidelines that deal with the labelling of genetically
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modified food. The WHO55 and the FAO

56

of the United Nations57 are the two bodies

that are responsible for safe and healthy practices and standards at the international level.
After almost 18 years of deliberations and discussion, the CCFL finally agreed on a code
of text with respect to the labelling of genetically modified food and the Compilation was
adopted by the CAC on July 5, 2011. Amid the widespread publicity and media claims
about the Compilation, the truth about what exactly was agreed upon by member
countries needs to be understood.

In a press release, Consumers International, a global voice for consumers operating in 115
countries, declared a “consumer rights victory” and said
The Codex Alimentarius Commission has been labouring for two decades to
come up with consensus guidance on this topic. …. The new Codex
agreement means that any country wishing to adopt GM food labeling will
no longer face the threat of a legal challenge from the World Trade
Organization (WTO). This is because national measures based on Codex
guidance or standards cannot be challenged as a barrier to trade.58

National legislations based on the Compilation will not be considered as a restrictive trade
practice in a WTO dispute. However, the Compilation recognizes that “each country has
the right to adopt its own approach to labelling GM food.”59 Thus, as countries are free to
determine their approach to labelling, the issue of a multitude of confusing regulations has
not been addressed in its entirety. The next chapter analyzes the problems of determining
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a standard of labelling at the international level, the role of CAC in addressing the issues
of labelling in international food trade and then reviews the Compilation.
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Chapter 3: Codex Alimentarius Commission
3.1

Background

The origins of the CAC can be traced back to the beginning of the 20th Century. In 1911,
Austria recognized the private notes of experts on the evaluation of food stuff as the
“Codex Alimentarius Austriacus.”60 “Codex Alimentarius” is a Latin term meaning “Food
Code.”61 The current CAC derived its name from the name of the food standards adopted
by the Austro-Hungarian Empire.62 Subsequently, in 1924, The South American Chemical
Congress called for the drafting of the Codex Alimentarius Sudamericanus, which
consisted of uniform guiding principles and set model standards for manufactured food.63
After World War II, there was an increased demand for more international co-operation.
In 1958, The European Codex Commission was set up set to effectively promote
international co-operation in setting a common “Food Code.” The European Codex
Commission promoted the idea that the objective of achieving an international food code
should be taken under the auspices of the United Nations.64 In 1960, the Food and
Agricultural Organization (FAO) Regional Conference65 endorsed the need for an
international agreement on the minimum food standards.

In 1961, with support of the WHO, United Nations Economic Commission for Europe

60

Richard Wildner, “Codex Alimentarius Commission”, online: (1973) 28 Food Drug Cosm. L. J. at 328
<http://heinonline.org/HOL/LandingPage?collection=journals&handle=hein.journals/foodlj28>
61
Henry I. Miller & Drew L. Kershen, “A label we don’t need”, Correspondence, Nature Biotechnology
(8 November 2011) 971-972 < http://www.nature.com/nbt/journal>
62
“Understanding The Codex Alimentarius”, 3rd Ed. (2006) online: Codex Alimentarius Commission at 6
<ftp://ftp.fao.org/codex/publications/understanding/Understanding_EN.pdf>
63
Franklin M. Depew, “National and International Food Standards”, online: (1964) 19 Food Drug Cosm. L.
J. at 492 <http://heinonline.org>
64
Ibid at 493
65
Supra note 62

25

and the Organization for Economic Co-operation and Development and the Council of the
Codex Alimentarius Europaeus, the FAO decided to establish the Codex Alimentarius
Commission. The FAO requested an early endorsement by the WHO, of a joint
FAO/WHO food standards programme. The FAO Conference also proposed that a joint
FAO/WHO conference be held in 1962. At the Joint FAO and WHO Food Standards
Conference, a proposal endorsing the Joint FAO/WHO Codex Alimentarius Commission
to be the principle organ for the joint FAO/WHO Program on Foods Standards was
adopted. The Conference also suggested that the first session of the CAC be held in
1963.66 In 1963, the WHO approved the establishment of the joint FAO/WHO Program
on Foods Standards, whose principle organ would be the CAC; it adopted the Statutes of
the Codex Alimentarius Commission and agreed to the calling of the first session of the
CAC.67

One of the preliminary purposes of CAC is the development of the “Codex Alimentarius”
or the “Food Code.” According to the Ontario Ministry of Food and Agricultural
Affairs68:
The Codex Alimentarius represents the world code of food standards. It is an
extensive 13-volume compilation of food Standards, Codes of Practice,
Guidelines and Recommendations. It is the world’s authoritative reference
on food standards, and is utilized by national food inspection systems, health
authorities, The World Trade Organization, the food industry, scientists and
consumer advocates.
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Thus Codex Alimentarius consists of a set of standards, codes of practices, guidelines and
other recommendations related to characteristics of food products. Some of the texts are
general and some are very specific. It could relate to a food or a group of foods, it could
also relate to the production and management of the food production process or the
operation of government regulatory systems for food safety and consumer protection.69

The Statutes and Rules adopted by the FAO in 1961 and by the WHO in 1963, provide the
legal basis for CAC. These Statutes state the concepts underlying the work of CAC and
the reasons for its establishment. According to Article 1 of the Statutes of the Codex
Commission,70 the purpose of Codex is as follows:

The Codex Alimentarius Commission shall, subject to Article 5 below, be
responsible for making proposals to, and shall be consulted by, the DirectorsGeneral of the Food and Agriculture Organization (FAO) and the World
Health Organization (WHO) on all matters pertaining to the implementation
of the Joint FAO/WHO Food Standards Programme, the purpose of which is:
(a) protecting the health of the consumers and ensuring fair practices in the
food trade;
(b) promoting coordination of all food standards work undertaken by
international governmental and non governmental organizations;
(c) determining priorities and initiating and guiding the preparation of draft
standards through and with the aid of appropriate organizations;
(d) finalizing standards elaborated under (c) above and, after acceptance by
governments, publishing them in a Codex Alimentarius either as regional or
world wide standards, together with international standards already finalized
by other bodies under (b) above, wherever this is practicable;
(e) amending published standards, after appropriate survey in the light of
developments.
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The purpose of CAC is to provide international standards to ensure the health and safety
of consumers worldwide and to guide member countries to adopt harmonious food
standards and thereby promote international food trade. This purpose is also reiterated on
the CAC website as follows71:
Codex Alimentarius follows the principle that consumers have a right to
expect their food to be safe, of good quality and suitable for consumption. In
this regard, the safety and essential quality of internationally traded food is
of paramount importance. Codex has set a number of standards and codes on
foods for vulnerable groups such as infants and young children, to provide
adequate nutrition while protecting them from foodborne risks and to reduce
infant mortality and morbidity worldwide.
Codex also aims at protecting consumers against deceptive practices. Codex
work in food labelling contributes to providing consumers with accurate and
useful information to guide their choice of food.
Codex assists in the harmonisation of national food legislation and regulation
of countries which want to use Codex texts as benchmark. International
harmonisation of standards facilitates food trade and sustainable economic
development. Codex plays an important role particularly for developing
countries that may lack the necessary infrastructure and expertise to put in
place adequate standards, food safety controls and management systems.
Although the adoption of the CAC’s texts is voluntary, many countries choose to adopt
these guidelines because policy makers see the benefit to consumers and international
food trade. By providing a harmonious standard that could be adopted worldwide, the
CAC texts serve a dual purpose of protecting consumer welfare and at the same time
promoting international food trade. The CAC texts are based on scientific principles;
hence, countries that do not have sufficient infrastructure and expertise consider the
CAC texts as valid standards of food safety and control over international food trade.
The guidelines/standards established by CAC are of a recommendatory nature and are
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not a substitute for national legislation. Countries may adopt these guidelines in their
national legislation and make provisions suitable to their specific requirements. This is
reiterated in the General Principles of the Codex Alimentarius as follows72:

Codex standards and related texts are not a substitute for, or alternative to
national legislation. Every country’s laws and administrative procedures
contain provisions with which it is essential to comply.
Codex standards and related texts contain requirements for food aimed at
ensuring for the consumer a safe, wholesome food product free from
adulteration, correctly labelled and presented….

Even though CAC standards are optional, most countries do adopt them because the
standards/guidelines are based on scientific principles. CAC strives to achieve a
consensus prior to the adoption of standards/guidelines/recommendations. Several rounds
of negotiations and discussions are held prior to the adoption of the CAC texts, and
member countries are given sufficient opportunities to express their concerns. This
transparency along with the scientific basis encourages member countries to adopt the
CAC texts in their national legislation.

Both the parent organizations (FAO and WHO) act as advisors to CAC. They have
convened expert meetings such as the Joint FAO/WHO Expert Committee on Food
Additives (JECFA), Joint FAO/WHO Meetings on Pesticide Residues (JMPR), the Joint
FAO/WHO Expert Meeting on Microbiological Risk Assessment (JEMRA), and ad hoc
FAO/WHO expert consultations to advise the CAC as well as member countries. FAO
and WHO also provide administrative, managerial, and financial support to the operation
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of the CAC and its committees, in particular those responsibilities assigned to WHO or
FAO in the Codex Procedural Manual.73 The Food and Agriculture Organization is
responsible for two-thirds of the funding, with WHO responsible for the other one-third of
funds for Codex, however, contributions from FAO have sometimes exceeded 80%.74

3.2

Structure of Codex

The CAC meets every year alternatively in Rome and Geneva. The structure of the CAC
consists of the Commission, the Executive Committee, and various subsidiary committees
that assist in developing food standards.75 CAC is also supported by its Secretariat. The
Commission may be considered as the plenary organ of CAC and it is open to all the
members. The Executive Committee, however, is a smaller body with a limited
membership, with the overall aim of ensuring a global geographical distribution.76
Currently, CAC has more than 184 member countries and one member organization (EU).
Its sessions are attended by national delegations including representatives from industry,
consumer organizations, and academic institutes. Countries that are not yet members
sometimes attend in an observer capacity. A number of international governmental
organizations and international non-governmental organizations also attend in observer
capacity.77 The countries or participants who attend in observatory capacity can put
forward their points of view at every stage except during the final decision. All decisions
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are an exclusive prerogative of member governments.

3.2 (a) Executive Committee
The Executive Committee of Codex comprises the Chairman, three Vice Chairs, and
seven elected representatives from the various geographical groups of CAC.78 Since its
formation, the Executive Committee has had representations from more than 45 different
countries from all over the world. The Executive Committee acts as the executive organ
of the Commission between sessions.79 The Executive Committee advises Codex and is a
smaller group with representations from all the regions80:
The Executive Committee advises the Commission on many questions and serves
as a “management board,” which would make it impractical to have it attended by
600 delegates (as in the Commission). Instead each region of the world is
represented in the Executive Committee through members that have been elected
into this position by the membership as well as regional coordinates and the
bureau of the Commission. The proceedings and audio recordings of the meetings
are later made public.
The Executive Committee advises the Commission on proposals for standards to be
developed by a subcommittees of Codex. It also serves as an arm of the Commission and
acts on behalf of the Commission in certain circumstances; for example, when the
Commission used to meet only once every two years, the Executive Committee could
advance steps on standards that were under review by the Commission.81 The Executive
Committee also makes proposals to the Commission related to new work to be undertaken
and the study of special problems, and it serves as the standard management body of
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CAC. The Committee generally meets prior to each session of the Commission, and at
other times during the year as needed.82

3.2 (b) Secretariat
The Secretariat provides administrative support to CAC and is headed by the Secretary.
The Secretary is appointed jointly by the Director General of FAO and WHO subsequent
to a worldwide search for qualified candidates. The Secretariat is based at the FAO
headquarters in Rome. It provides administrative support for both the Commission and the
Executive Committee. The Secretariat is responsible for the preparation of the agenda
item papers for the meetings, preparation of reports of the meetings, and also necessary
follow up activities that are required subsequent to meetings of both Commission and
Executive Committee. When the Executive Committee or the Commission decides to
develop a new standard, usually the Secretariat drafts a discussion paper detailing what
the proposed standard is expected to achieve and a project proposal indicating the time
frame for the work and its relative priority. The Secretariat also assists in the preparation
of proposed draft standards.83 The Secretariat is responsible for overseeing, coordinating,
and dispersing information about the meetings, agendas, discussion papers, and reports of
the subsidiary bodies to the member countries.84
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3.2 (c) Subsidiary Bodies
The task of developing CAC standards is carried out is by specific subsidiary bodies.
Under the “Rules of Procedure of the Codex Alimentarius Commission”85, CAC is
empowered to establish two kinds of subsidiary bodies: Codex Committees and Coordinating Committees.86 The Codex Committees are further classified into General
Subjects Committees and Commodity Committees. The Codex Committees are
responsible for the preparation of draft standards for submission to the Commission. The
Co-ordinating Committees represent specific regions around the world or a group of
countries. They are responsible for co-ordinating food standards activities in the regions
they represent. Each Co-ordinating Committee is also responsible for the development of
standards specific to the region that it represents.87

Each committee, with a few exceptions, is hosted by a member country. The host country
is responsible for the cost of the Committee’s maintenance and administration and for
providing its chairperson. The Commission is responsible for the allocation of the
committee to member countries.88

The powers of the Commission to establish the above subsidiary bodies have been
specified both in its Statutes as well as in its Rules of Procedure. Article 7 of the Statutes
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of the Codex Alimentarius Commission89 states that “The Commission may establish such
other subsidiary bodies as it deems necessary for the accomplishment of its task, subject
to the availability of the necessary funds.” Thus the only precondition, according to this
article, that the Commission or the Executive Committee has to consider prior to setting
up a subsidiary body is that there should be sufficient funds to enable proper functioning.
Rule XI of The Rules of Procedure of the Codex Alimentarius Commission, 90 however
elaborates more detailed requirements for establishing the subsidiary bodies. It specifies
the different types of subsidiary bodies that CAC can establish, their role, how
membership to such subsidiary bodies will be determined, how the chairpersons and
coordinators will be appointed, who can convene the sessions of the subsidiary bodies,
who determines the place of meetings of these subsidiary bodies, and the funding
requirements for functioning of the subsidiary bodies.91 Rule XI of the Rules of Procedure
has been incorporated in this thesis as Appendix II.

According to the Rules of Procedure the conditions necessary for the establishment of a
subsidiary body are that, first, CAC must deem it necessary for the development of a
standard or the task that it seeks to achieve and, second, there must be sufficient funds to
achieve the purpose. Decisions regarding funding requirements are based on the report of
the Director General of the FAO and/or WHO as appropriate. Such reports usually detail
the administrative and financial implications of establishing a subsidiary body. 92 Thus the
availability of funds is an important factor in establishing a subsidiary body, and member
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countries that are willing to bear the costs of its functioning are allotted a committee.

3.3

Types of Codex Committees

There are two types of Codex Committees, based on the kind of function they perform.

3.3 (a) General Subject Committees
As the name indicates, the functions performed by such committees are of a general
significance, i.e., applicable to all food categories. They are also referred to as “horizontal
committees.” They develop guidelines, standards and concepts that are all-embracing and
apply to all foods in general, they endorse or review relevant provisions in CAC
commodity standards, and, based on the advice of expert scientific bodies, develop major
recommendations pertaining to consumers’ health and safety.93 The committees deal with
definitions, rules of procedure, working procedures for the establishment and operation of
Codex Committees and Task Forces, relations with other organizations, minimum limits
for additives and contaminants, and other similar principles of a general nature with
respect to the preparation of CAC standards and codes of practice.94

Some of the General Subjects Committees and their roles are summarized below95:
Six of the General Subject Committees have the responsibility of ensuring that
specific provisions in CAC commodity standards are in conformity with the
Commission’s main general standards and guidelines in their particular areas of
competence. They are:
 Committee on Food Additives

93

Supra note 62 at 17
Supra note 62 at 17
95
Supra note 62 at 17 and 18
94

35







Committee on Contaminants in Foods
Committee on Food Hygiene
Committee on Food Labelling
Committee on Methods of Analysis and Sampling
Committee on Nutrition and Foods for Special Dietary Uses

3.3 (b) Commodity Committees
The role of these committees is to develop guidelines and standards that are specific to a
particular type of food or class of food. Such committees are also referred to as “vertical
committees.” These committees meet as and when necessary, sometimes annually or biannually. The committees are attended by almost all the member countries and sessions
are as large as that of the plenary session of the Commission itself. After completing the
work allocated to them, the committees are either suspended or abolished. New
committees are established on an ad hoc basis to develop specific standards.96 It is in such
committees that individual countries must express their opinions and concerns prior to the
development and adoption of a standard. Once a standard is developed and accepted it is
accepted as a world standard, and member countries cannot do much to alter the position
later. Hence, there is extensive participation by member countries in these committees.
Some examples of commodity committees are Committee on Fats and Oils, Committee on
Fish and Fishery Products, Committee on Fresh Fruits and Vegetables, Committee on
Milk and Milk Products, and Committee on Processed Fruits and Vegetables, etc.97
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3.3 (c) Ad hoc Intergovernmental Task Force
Due to the extensive participation in the committees, the Commission realized that to
make sufficient progress they needed a more flexible approach that could help develop
standards and guidelines across an ever-widening range of subjects. In 1999, CAC
decided to create a third type of subsidiary body called the “Codex ad hoc
Intergovernmental Task Force.” These committees have very limited terms of reference or
are established for a fixed period of time.98 Since their inception many task forces have
been established that have significantly helped to make progress toward the development
of new CAC standards and guidelines. In 2000, CAC established the Intergovernmental
Task Force on Biotechnology, which has significantly contributed toward the
development of four guidelines on risk analysis and food safety of foods derived from
biotechnology. These guidelines were incorporated into the final Compilation.

3.3 (d) Coordinating Committees
These committees represent the regional interests or group interests of the member
countries. They perform an important role in ensuring that the regional or group concerns
are addressed, including the concerns of developing countries. There is significant
participation in the meetings of the Coordinating Committees. The reports of the meetings
of these committees are submitted to and discussed by the Commission. The country that
chairs the Coordinating Committee is also the Regional Coordinator for the region.99 The
meetings are usually hosted on a need to basis by one of the members of the region that
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the committee represents, based on discussions with CAC. There are six Coordinating
Committees, one each for the following regions: Africa, Asia, Europe, Latin America and
the Caribbean, Near East, and North America and the Southwest Pacific.

A tabular representation of the structure of the various committees of the CAC is shown
in the figure below

38
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3.4

Procedure adopted for drafting standards at Codex

As stated in Article 1 of the Statutes of the Codex Commission, the primary purpose of
Codex is to draft and publish the “Codex Alimentarius” or the “Food Code.” The legal
principles of Codex are published in The Procedural Manual of the Codex Alimentarius
Commission. The procedure for preparing the food code is well defined and
transparent.101 According to the Procedural Manual of the Codex Alimentarius
Commission,102 an initial submission is made either by a national government or a
subsidiary body to the CAC or the Executive Committee on the need to develop a
standard. Based on this proposal a discussion paper stating the purpose of the standard,
the time frame, and the priority is presented to the Commission and/or the Executive
Committee for its review. The Commission and the Executive Committee decide on the
proposal based on the “Criteria for Establishment of Work Priorities.” The Criteria for
Establishment of Work Priorities is also detailed in the Procedural Manual of the Codex
Commission. The Commission and/or the Executive Committee also decide the subsidiary
body that would carry out the necessary work. Sometimes the nature of the work might
demand the creation of a new subsidiary body or the revival of a subsidiary body that has
been adjourned sine die. At other times a specialized task force may be created.

The Secretariat prepares a proposed draft standard and submits the same to the
governments of the member countries for their comments. Such comments are reviewed
by the subsidiary body that has been allocated the responsibility of developing the
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proposed standard. After discussions the subsidiary body may present the amended text as
a draft to the Commission. The proposed draft may also be referred to a General
Committee – such as the Committee on hygiene, labelling, additives, contaminants, etc. –
for specific advice in their respective areas. Subsequent to the recommendations of the
Commission and/or the General Committee, the proposed draft is then sent to the
governments of member countries for their concerns or comments. The Subsidiary body
reconsiders the proposed standard based on concerns raised and, after making necessary
modifications as required, resubmits the amended proposed draft to the Commission.
After considering the proposed draft the Commission may choose to adopt the text of the
proposed draft and included it in the Codex Alimentarius.103

The detailed steps for developing a standard at CAC are contained in the “Procedures for
Elaboration of Codex Procedures and Related Text,” Section II of Procedural Manual 104
and is included in this thesis as Appendix I. A summary of the steps involved is as
follows:


Step 1 the Executive Committee reviews the request for a new standard in the
light of criteria and priorities established by CAC and delegates the matter to a
particular Codex Committee.



Step 2 a draft is prepared.



Step 3 the draft is circulated to member countries and observer participants.



Step 4 the draft and comments of member countries and observers is reviewed by
the Codex Committee and if necessary a new draft is made.

103
104

Supra note 62 at 16
Supra note 100 at 31

41



Step 5 if the Codex Committee agrees that sufficient progress has been made and
there is consensus, it agrees to proceed towards finalisation.



Step 6 the draft is referred to the General Standards Committee or any other sub
committee to check for compliance with other CAC standards.



Step 7 the draft is reconsidered and finalised based on the suggestions of the
committees of CAC.



Step 8 the draft is referred to the Commission and is adopted by it as a formal
Codex text.

An analysis of the steps involved indicates the numerous opportunities for member
countries and other participants to express their concerns and points of view. Right from
the inception of a proposed draft in Step 1, the committee involved provides opportunity
for participants in Step 2, 3, 4 and 5 to express their concerns to the proposed draft. If
necessary, a new draft is prepared based on the comments of participants.

Because CAC attempts to develop standards on a consensual basis, the process of
developing a new standard usually takes several years. In its Procedural Manual, the
Codex Committee in 2003 adopted “Measures to Facilitate Consensus.”105 These
measures provide for through discussions and documentation of the issues at meetings,
provisions to organize informal meetings to address disagreements and controversies,
ways to address all relevant concerns before proceeding to the next steps, and the
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facilitation of increased involvement and participation of developing countries.

Sometimes after the matter has been discussed and sufficient progress has been made at
Step 5, a subsidiary body/committee may decide based on the consensus of the members
that the proposed draft standard progress directly to Step 8. Such a procedure is termed
Step 5/8. Usually only texts that are considered to be ready for final adoption proceed to
Step 5/8. The Secretariat will submit the proposed draft standards submitted by the
subsidiary body/committee along with comments from member countries for the final
review and adoption by the Commission.

Sometimes an accelerated procedure may be adopted by the committee based on a
consensus by a two-thirds majority of members of the committee along with subsequent
approval by the Commission or by an approval based on a two-thirds majority of
members of the Commission. A decision to adopt an accelerated process is based on the
outcome of a critical review by the Executive Committee. The method for adoption of an
accelerated procedure is also contained in the Procedures for Elaboration of Codex
Procedures and Related Text,” Section II of Procedural Manual.106 The procedure is
similar to the one described above; however, when the Secretariat circulates the proposed
draft to member countries and other observer countries or organizations, they are
informed that the matter is being reviewed under the accelerated procedure. Countries and
organizations can comment on all aspects, including the impact on economic interests. At
Step 5 the matter is sent to the Commission and the Executive Committee along with the
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comments of member countries and other observer countries and organizations.107

Subsequent to the review by the Commission and the Executive Committee, the
Commission may decide to adopt the standard and require that the same be published by
the Secretariat. Subsequent to its adoption, the Secretariat will publish the same in the
Codex Alimentarius and notify all member countries and other international
organizations. The member countries and the international organizations notify the
Secretariat about the status or the use of the CAC standard as required by the General
Principles of the Codex Alimentarius. Paragraphs 4, 5, and 6 state the types of notice that
member countries can issue: Countries may accept the CAC standard completely or with
certain deviations. The Secretariat is required to publish such notifications as well in the
CAC Alimentarius.108

3.5

Codex Alimentarius Commission’s Standards and Scientific Analysis

The standards, codes, and guidelines developed by CAC are based on sound scientific
principles. The scientific issues considered in the CAC documents relate to its two
primary purposes: 1) the protection of consumer health through improving quality and
safety, and 2) the promotion of fair practices in international food trade.109 It has been
observed that “science, with its proverbial reputation of objectivity, has been identified
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and increasingly implemented in international agreements regulating trade in food,
including CAC documents and WTO agreements.”110 The scientific validation of the CAC
principles has made it possible for member countries to adopt and apply the CAC
standards in their respective national legislation. This in turn has promoted international
food trade as sound scientific principles contributed to the removal of non-tariff trade
barriers. CAC has delivered standards and guidelines about safety of new technologies.
This has also helped developing countries who lack the resources to undertake such
analysis. CAC standards have helped to bring about harmonization in requirements in
international food trade.111

The work of CAC has been supported and validated by several experts and specialists in a
wide range of disciplines from all over the world.112 A review of the CAC’s history
indicates the role of science in helping CAC guide its work.
In 1995, the Commission adopted four Statements of Principle Concerning
the Role of Science in the Codex Decision- Making Process and the Extent
to Which Other Factors are Taken into Account. These principles were
supplemented by Statements of Principle Relating to the Role of Food Safety
Risk Assessment (1997) and by Criteria for the Consideration of the Other
Factors Referred to in the Second Statement of Principle (2001). A
comprehensive statement of Working Principles for Risk Analysis in food
safety and health was adopted by the Commission in 2003 and incorporated
into the Procedural Manual of the Codex Alimentarius Commission.113

The above principles have been adopted based on the fundamental understanding of the
CAC paraphrased as follows:
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1. Excellence: CAC recognizes and adopts internationally recognized expertise and also
generated and global scientific discussions based on best practices.
2. Independence: The scientific advice received and adopted by CAC is from experts
who act independently and do not represent the governments of member countries or
any institution. Experts are required to declare any possible conflict of interest.
3. Transparency: By adopting the above science-based principles, CAC tries to maintain
transparency. All member countries have access to all reports, safety assessments and
evaluations, and other necessary information.
4. Universality: As the CAC standards are adopted world wide, the underlying principles
have to be universally applicable. It is for this reason that CAC seeks the advice of
experts and specialists from all over the world.114

The scientific analysis that supports the CAC standards is carried out in the form of
collaborative studies among individual scientists, laboratories, universities, and joint
FAO/WHO expert committees. The joint expert committees are independent bodies
composed of highly skilful and impartial members, whose decisions are indisputably
objective.115 CAC also collaborates with other international organizations such as the
International Atomic Energy Agency and World Organization for Animal Health to
provide scientific advice to promote food safety.116 A brief summary of the above
scientific principles is stated below to better understand the underlying principles of the
Codex Alimentarius.
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3.5 (a) Statements of Principle Concerning the Role of Science in the CAC DecisionMaking Process and the Extent to Which Other Factors are taken into Account 117:
The purpose of these statements is to highlight the importance of science in developing
CAC recommendations. The first statement in this principle of the role of science states
that:
The food standards, guidelines and other recommendations of Codex Alimentarius
shall be based on the principle of sound scientific analysis and evidence, involving
a thorough review of all relevant information, in order that the standards assure the
quality and safety of the food supply.118

The principles require a thorough examination of all relevant scientific evidence prior to
the Committee making a recommendation. Requirements contained in these statements
include, among others, the following: when conducting a risk analysis for the
development of CAC standards, risk assessment and risk management should be
separated; all other factors that risk managers propose to take into account should be
recorded; and statements indicating how such factors affect risk management options
should also be recorded. The principles recognize the “other factors taken into account”
on the condition that such other factors should not create unjustified barriers to trade. By
adopting a clear scientific basis and transparent approach, these principles promote the
two preliminary purposes of CAC, i.e., promotion of consumer health and safety and
promotion of fair international food.
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3.5 (b) Working Principles for Risk Analysis for Application in the Framework of
the Codex Alimentarius119
This guideline was adopted by the CAC in 2003 and is intended to provide guidance to
CAC and the expert committees in determining the health and safety standards on a
scientific and transparent basis. According to this working principle, risk analysis should
consist of three components: risk assessment, risk management, and risk communication.
The definitions of risk assessment, risk management, and risk communication are as
follows:
Risk Assessment
A scientifically based process consisting of the following steps: (i) hazard
identification, (ii) hazard characterization, (iii) exposure assessment, and (iv) risk
characterization. Risk Management
The process, distinct from risk assessment, of weighing policy alternatives,
in consultation with all interested parties, considering risk assessment and
other factors relevant for the health protection of consumers and for the
promotion of fair trade practices, and, if needed, selecting appropriate
prevention and control options.
Risk Communication
The interactive exchange of information and opinions throughout the risk
analysis process concerning risk, risk-related factors and risk perceptions,
among risk assessors, risk managers, consumers, industry, the academic
community and other interested parties, including the explanation of risk
assessment findings and the basis of risk management decisions.120

The above definitions indicate the complex nature of study prior to the development of
CAC standards and guidelines. The Working Principles require that risk analysis should
be based on thorough consultation with all interested parties and that separation should be
maintained between risk assessment and risk management in order to assure scientific
119
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integrity. The Commission provides advice on risk management while the joint
FAO/WHO expert bodies and consultations provide advice on risk assessment.121 The
Commission considers all other relevant factors, such as economic implications, societal
impact, and the like before developing its report on risk management.

The significance of science in determining the CAC standards, code and guidelines is well
accepted by member countries and has helped in promoting international trade.
Codex member countries have understood from the outset that effective
implementation of food legislation requires science-based systems to assure
the best consumer protection and to enable clear justification of actions taken
to courts, policy makers, and to consumers. It is clear that all matters related
to the control of quality or safety of foods, such as net weight, volume,
ingredient lists, claims, additives, pesticide or animal drug residues, control
of contaminants or food hygiene, must be based on good science.122

The transparency with which CAC conducts its risk analysis and the open access it
provides to all promotes acceptance and justification of all CAC standards, codes, and
guidelines with national policy makers, judiciary, and consumers. Scientifically justified
policies promote better harmonization of international food trade policies.

3.6

Codex Committee on Food Labelling

The Codex Committee on Food Labelling (CCFL) was set up in 1964 with a mandate to
draft provisions on labelling that would be applicable to all foods, to draft provisions on
labelling concerning products given priority by CAC, namely products referred to
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specific Codex Committees for the elaboration of standards, and to study specific
labelling problems assigned to it by the Commission or the Executive Committee.123
Later the terms of reference were expanded to include a reference to study problems
associated with the advertisement of food with particular reference to claims and
misleading descriptions.124

The CCFL is a general committee that is entrusted to draft standards around labelling.
Such standards may be general and applicable to all foods, such as the standards that
name and provide contents of the products or it could be specific, such as the standards
on labelling of “Halal” products. The CCFL also considers, amends, and endorses drafts
of specific provisions on labelling prepared by other committees and studies specific
labelling problems assigned by the Commission or the Executive Committee.125

In 1964, CAC accepted Canada’s offer to host the CCFL. Canada is responsible for
providing financial and administrative support for the functioning of CCFL, and the
CCFL is chaired by a Canadian national. The host country is consulted by the Director
General of FAO and WHO before fixing the time and place of the CCFL meeting. The
Procedural Manual of the Codex Commission contains the “Guidelines for the conduct of
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meetings of Codex Committees and ad hoc intergovernmental task forces.” 126 These
guidelines regulate and guide host countries on how committee meetings are to be
conducted, how standards are to be developed, how reports are to be drafted, and criteria
for drafting CAC standards.

3.7
1.

History of development of the Compilation
The initial consideration of the proposal to develop labelling standards was in 1993
at the 22nd session of CCFL.127 The CCFL decided to undertake a study on the
Implications of Biotechnology on International Foods Standards and Codes of
Practice. It asked governments to provide information on national approaches to
labelling of foods and food ingredients or additives produced through
biotechnology. The CCFL asked the US to prepare a discussion paper for
consideration in the next session.

2.

In 1994, at the 23rd session, the CCFL128 met to review the discussion paper
proposed by the US on the implications of biotechnology. The document highlighted
developments in biotechnology, previous discussions within CAC with focus on
labelling, including enforcement, and the current status of labelling. The paper
identified a number of issues for which further elaboration and comments were
required, such as the relationship between genetic engineering and conventional
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breeding techniques, scientific safety evaluation of substances obtained through
recombinant DNA techniques, the use of marker genes, allergenicity, and ethical
considerations.129

Several countries expressed concerns about the lack of time to sufficiently review
the document. Some delegations expressed the view that it was too early to decide
on particular rules for products obtained through biotechnology, and that labelling
was necessary when the food or ingredient was significantly different from its
conventional counterpart, or if safety concerns were involved. Other countries
stressed the necessity for full information, as new technologies could benefit the
consumers as well as the industry, and transparency in such instances could only
help build confidence between the industry and the consumer. The Delegations of
Indonesia and Romania suggested that the term “genetically engineered foods”
should be used throughout the discussion instead of “biotechnology,” as
biotechnology covered a broad spectrum of processes and disciplines.130

Some countries, such as the US, were of the view that foods derived from the use of
genetic modification should be determined safe for consumers and meet the same
high standards as foods made by other techniques, labelling should be determined on
a case-by-case basis only when a real modification in the composition of the food
had taken place, and no general labelling requirement for all foods derived from the
use of genetic modification techniques should be made. They also held that all
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decisions should be based on science.

However, some other countries and consumer organizations were in favour of
mandatory labelling for foods obtained through biotechnology, as this would enable
consumers to make an informed choice. Further concerns about the impact on
biodiversity were raised by observer non-governmental organizations. Hence, CCFL
felt the need for more elaborate discussions and comments to the discussion paper
and decided to adjourn the matter to next session.

A review of this report indicates that the differences in the ideologies to labelling
were noticeable right from the inception. The use of the term “modern
biotechnology” in the present draft compilation could be attributable to the concerns
raised in this meeting of the CCFL. The differences expressed in this session on
whether to label GM food and food additives could not be resolved until the very
end.

3. In 1996, at the 24th session,131 the differences became more entrenched. Participants
were divided, with some demanding compulsory labelling of all food derived from
biotechnology, while others felt that labelling should be adopted on a case-by-case
basis. As the CCFL experienced a deadlock, it decided to refer the matter to the
Executive Committee for guidance on how to resolve these differences and also on
how to implement the four “Statements of Principle concerning the role of science in
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the CAC decision-making process and the extent to which other factors are taken into
account”.132 It also recommended that the Secretariat take responsibility of writing
the “draft standards.” In the meantime, the FAO and the WHO had set up a joint
expert commission to study the safety aspects of food derived from biotechnology.
The CCFL suggested that the Secretariat should consider the report and
recommendations of the expert commission as well.133

In 1996, several countries were still in the process of developing national standards,
which was mentioned by the EU and Canada and acknowledged by the CCFL.
Because countries had not yet finalized their national policies there was firm divide
in the drafting of labelling standards and progress could not be made. The referral to
the expert committees was in pursuance to the CAC’s commitment to base its
standards on sound scientific principles and to ensure the health and safety of
consumers.

4.

In 1997, in the 25th session,134 the CCFL had not received a draft from the
Secretariat, as several member countries had not provided their comments to the
draft proposed by the Secretariat. The Secretariat also suggested that the
recommendations had been presented in the form of an amendment to the “General
Labelling Standard, following the approach taken for similar issues, and presented
the conclusions of the Expert Consultation of particular relevance where labelling

132

Supra note 100 at 209
Supra note 131
134
CCFL, 25th Sess, ALINORM 97/22A (1997),
<http://www.codexalimentarius.org/committees-task-forces/en/?provide=committeeDetail&idList>
133

54

was concerned.”135 The EC and some other countries approved the same in light of
the recommendations of the Joint Expert Committees of the FAO and WHO. Some
member countries expressed the view that the draft focused on food safety rather
than food labelling and hence needed to be redrafted. The need to use “modern
biotechnology” to differentiate from conventional breeding was reiterated. As many
countries reiterated the need for more time due to the implications both to
consumers and industry, it was agreed to adjourn the matter to the next session.136

5.

In 1998 at the 26th Session137, the CCFL introduced the draft prepared by the
Secretariat that was modified based on member’s comments, called the “Draft
Recommendations for the Labelling of Food Obtained through Biotechnology.”
Some countries and the EC were in favour of labelling “all foods containing GMOs
and of foods produced from GMOs but not containing them when no longer
equivalent to existing foods or ingredients.”138 They were of the opinion that this
would ensure transparency and address consumer concerns. This was, however, not
acceptable to certain non-governmental organizations such as Consumer
International and the International Federations of the Organic Agricultural
Movements or to some countries, such as Norway and India. The demand for the use
of “modern biotechnology” was reiterated and was accepted by the CCFL at this
session. The CCFL also decided to amend the definitions and to re-circulate the
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amended draft for comments. Thus, the proposed draft did not move beyond Step 3,
although progress was made in the proposal of mandatory labelling in the presence
of allergens such as milk proteins. If labelling was not possible then it should not be
marketed. The section proceeded to Step 5.139

A review of the report indicates the complexity in arriving at a consensual decision.
This session also marks the beginning of the manner in which CCFL proceeded with
acceptable provisions, which finally contributed to the adoption of the Compilation.
The discussions in this session indicate the ideologies of different countries – some
countries of the EU and India favoured mandatory labelling, whereas, Canada, the
US, Brazil, and Australia supported labelling on safety, composition, intended uses,
and nutrition.140

6.

In 1999, the 27th session of the CCFL141 reconvened to consider the comments to the
Draft Recommendations for the Labelling of Food Obtained through Biotechnology.
This session saw more extensive participation and further crystallization in terms of
support of the mandatory labelling versus those who advocated labelling only if
there was a change in composition, use or nutritional quality. Further, there was
more extensive participation for non-governmental organizations. The extensive
debate indicated a lack of consensus, and hence CCFL established an Ad Hoc
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Working Group to consider the definition of biotechnology-derived foods and to
establish the two labelling options to be considered by the CCFL later.

The first option would require the labelling of products when they are obtained
through biotechnology and differ significantly from the corresponding food with
regard to composition, nutritional value, or intended use. The second option
involved mandatory labelling based on the method of production. The Working
Group was also to look into the establishment of a threshold level in food or in food
ingredients for the presence of food or food ingredients obtained through modern
biotechnology, below which labelling would not be required. They were tasked also
with the establishment of a minimum threshold level for “adventitious” or accidental
inclusion in food or food ingredients, of food or food ingredients obtained through
biotechnology.142

7.

In 2000, at the 28th session of the CCFL143, the Working Group submitted its report.
US and some other countries raised new concerns: they stressed the need to address
all the implications of labelling foods derived from biotechnology with respect to
enforcement, methodology, economic cost, and consumer perception, and proposed
that the CCFL, with the assistance of the Working Group, should consider these
aspects carefully before taking a decision on mandatory labelling provisions. It was
also pointed out that developing countries would face technical difficulties in
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implementing provisions for the labelling of foods derived from biotechnology.144

There was also further discussion on the use of the term “modern biotechnology.”
The CCFL agreed to replace the words “food and food ingredients obtained through
modern biotechnology” with the words “food and food ingredients obtained through
certain techniques of genetic modification/ genetic engineering” throughout Section
2 and in the Title. The use of the term genetic modification or genetic engineering
was first suggested by Consumer Rights International, when the CCFL decided to
use the term modern biotechnology instead of biotechnology at the 26th session.

The CCFL recognized the diversity in opinions among the member countries and
decided to refer the matter for further consideration by the Working Group in light
of the new concerns raised by US and other supporting countries. It was also
decided that the threshold limits identified by the Working Group should be
recommended to the Codex Committee on Method of Analysis and Sampling to
review the analytical method of determining the threshold. Thus, the matter did not
proceed to the next step and was sent for reconsideration.

The global discussions on the safety of food derived from biotechnology due to the
controversial studies in Europe about the safety of genetically modified food led to
the Commission setting up an Ad Hoc Intergovernmental Task Force on Foods
Derived from Biotechnology. The terms of reference to the intergovernmental
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taskforce were:


To elaborate standards, guidelines, or other principles, as appropriate, for
foods derived from biotechnology;
 To coordinate and closely collaborate, as necessary, with appropriate
Codex Committees within their mandate as related to foods derived from
biotechnology; and
 To take full account of existing work carried out by national authorities,
FAO, WHO, other international organizations and other relevant international
fora.145

This intergovernmental taskforce undertook to work on the Draft Principles for Risk
Analysis of Foods Derived From Modern Biotechnology, and the Draft Guidelines
for the Conduct of Food Safety Assessment of Foods Derived from Recombinant–
DNA Plant. The significance to determine the safety of foods derived from
biotechnology led to its final inclusion in the Compilation.

8.

In 2001, at the 29th session146, differences continued and no progress could be
made. Argentina requested that no further work be undertaken on this project. They
expressed the view that labelling based on process might lead to an impression
among consumers that the food was not safe and that this was against the “Statement
on Principles on the Role of Science and the Extent to which Other Factors are taken
into Account”.147 Therefore, they did not wish to pursue a labelling standard based
on the process of production. Some countries also questioned the development of
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guidelines that would provide different options according to the regulatory approach
taken in member countries, since this was not the usual approach in CAC and it was
not clear how this would apply in case of trade disputes. These delegations indicated
that CAC should rather give general recommendations that could be applied in all
countries as a basis for international harmonization. The problem of “verification”
was also raised in this session, and a suggestion was made that only information that
could be varied should be labelled. Italy suggested the idea that labelling should be
throughout the food chain and not just at the point of consumption.148

It should be noted that these reservations for alternative methods of labelling were
made in 2001, and despite this, the adopted Compilation does state that countries are
free to adopt a labelling strategy suitable to its requirements.

The CCFL moved a compromised section on definitions to Step 8 for adoption by
the Commission by including that “the definitions in the current text were retained
and clarified and the definition of ‘modern biotechnology’ was added, in order to
take into account the different approaches taken by member countries as regards the
definitions under consideration in the CCFL.”149 The concerns raised with respect to
the alternative labelling options complicated the matters further, and the matter was
referred back to the working group for reconsideration and for comments from
participants.
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9.

In 2002, at the 30th session of the CCFL150, the committee had to reconsider the
section on definitions, as the Commission had referred it back to Step 6 for
reconsideration due to the lack of consensus. The definition of the term “modern
biotechnology” was again discussed with not much progress being made. The CCFL
noted that the term “modern biotechnology” was being used in the proposed draft of
the Ad Hoc Intergovernmental Taskforce on Foods derived from biotechnology.
Many countries were of the opinion that a similar definition should be incorporated
to maintain consistency. However, several others were concerned about the use of
term modern biotechnology as they felt consumers would not understand the same.
Spain suggested that a footnote be included that stated that the use of the term
modern biotechnology would not be applicable to the language used in labels.
Though some countries accepted Spain’s position, there was no consensus and the
matter was referred to the work group.151

Deliberations with respect to the labelling options also could not move further as
new concerns were raised and old concerns were crystallized. The use of the term
“genetic engineering or genetic modification” in the title was sought to be replaced
with modern biotechnology and this was opposed. Labelling of food based on the
process of production was opposed by several countries, including US, Argentina,
and Brazil. Canada and a few other countries suggested that voluntary labelling
could be included for products that were not different from their conventional
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counterparts. This was not acceptable to some members. The determination of
threshold was also disputed, with some countries stating that there should be no
threshold while others stating that there should be provisions of adventitious
inclusion in the production process. With respect to the provisions of exemptions,
some members were of the opinion that some products could be excluded while
others felt that there should be no exemptions. Finally, with respect to the labelling
declarations some countries stressed the need for verification methods, while others
felt this matter needed further discussions.152

CCFL recognized that no consensus could be reached on several important sections
and thereby referred the draft recommendations on labelling back to step 3 for
further comments.

10.

In 2003 at the 31st session,153 the CCFL recognized the difficulties in coming to a
consensual decision. The chair called for establishment of a group called “Friends of
the Chair,” as an inter-sessional mechanism to break through the difficulty that
CCFL was facing. The participants agreed to this proposal on the condition that
transparency and balanced geographical representation between developed and
developing countries would be maintained. The CCFL decided to adjourn the
discussion on draft definitions to Step 7 and the proposed draft guidelines to Step 4
for further discussions in the next session. Thus, nothing significant was achieved in
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this session and much was hoped to be achieved in the smaller group setting that
was to be convened subsequent to the CCFL meeting.154

11.

In 2004 at the 32nd session155, the CCFL started with the mandate to develop
options for the management of this agenda item. The working group “Friends of the
Chair” had recommended that work be continued on this item, and considerable
interest was expressed in maintaining a single document with mandatory
components and other optional provisions. No consensuses could be reached with
respect to the exact nature of the components. The working group had also
suggested that the matter be referred to the FAO, WHO, and the WTO as the CAC
standards had significant implications on a WTO dispute. Some of the concerns
raised were the possible impact on food prices in developing countries should
labelling be mandated on process and the impact of such labelling on the Agreement
on Technical Barriers to Trade.156 Many countries highlighted concerns that lack of
harmonization regarding labelling of foods derived from modern biotechnology
could lead to trade barriers in international food trade. As some participants
expressed concern on referring the matter to FAO, WHO, and WTO, the committee
agreed to return to the proposed draft in the next session. Thus no progress was
made on key issues except for highlighting the costs of mandatory labelling.157
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12.

In 2005, at the 33rd session of the CCFL158, the stalemate continued. Despite the
matter being referred back for further comments, no agreement could be reached.
Canada suggested that the proposed draft guideline consist of two components, one
in which there is mandatory labelling in the case of changes in nutrition content,
composition, end use, or presence of allergens; and an optional provision linked to
voluntary labelling of the method of production by the industry. Several countries
were against adopting labelling based on production because it would result in
increased price and lead to inaccurate and misleading labels, and because they were
of the opinion that it was against the Statements of principles on the role of science.
The committee decided to establish an electronic working group in order to make
progress for consideration at the next session. In addition, no progress was made
with respect to the deliberations on the definitions section.159

13.

In 2006, at the 34th session of the CCFL160, the electronic working group had
reconstructed the guidelines, including mandatory provisions for health- and safetyrelated labelling and the optional method of production-labelling provisions. Many
participants expressed their concerns over these amended guidelines, and no
progress could be made. Suggestions were made to discontinue work on this agenda
as no consensus could be reached. However, some countries expressed that
discussions should continue given the importance of this topic to consumers and to
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developing countries, as it would facilitate the establishment of national policies in
such countries. The chairperson noted the considerable support to continue work and
decided to establish a physical working group to consider all relevant issues and
identify main problems. The mandate of the working group was to consider the
rationale to the members’ approach to labelling, identify current labelling standards,
regulations, or policies, identify members’ practical experiences in applying and
implementing labelling policies, and identify strategies used to communicate to the
public about foods and food ingredients obtained through certain techniques of
genetic modification/genetic engineering with particular reference to how members
label these foods.161 It was also established, with a view to promoting better
communication with participants, to arrive at a consensual path. The CCFL agreed
to leave matters undecided and reconvene in the next session, based on the
recommendation of the working group, that had just been established in this session.

14.

In 2007, at the 35th session of the CCFL162, discussions were primarily based on the
safety of GM food. The Inter-governmental Task Force on Foods Derived from
Biotechnology stated that several elaborate tests had been adopted by the
commission to address risk analysis and safety assessment for foods derived from
recombinant DNA, plants, and micro-organisms. Therefore the safety concerns
about GM food were sufficiently addressed. Several participants reiterated the need
for mandatory labelling to respect the consumers’ right to information. Others
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opposed this view stating that the consumers’ right was not one of the rights
included in CAC’s purpose in the Statutes of the Codex Alimentarius Commission.
The working group had come up with different approaches to labelling; however, no
consensus was reached. The working group had also identified possible options for
further action by CCFL but had not considered them in detail due to the lack of time.

Though the working group had made some progress, it was not sufficient, and hence
CCFL decided to establish another physical working group between sessions. There
was a demand to abandon the work on this item as some thought that no consensus
could be reached. However, others reiterated the importance of this work and the
CCFL decided to set a timeline for the completion of this task as 2011. The
mandate of the working group

was to look at the problem with a different

perspective. This time the working group was asked to identify the rationale of not
adopting a particular approach; it was asked to revisit communication strategies and
to review current CAC texts to determine if they provided sufficient guidance.
Based on this review they were to determine a way forward. The working group was
to base its decision on previous guidelines, discussions held at the CCFL meetings,
informative background papers prepared by US , the guidelines of the Executive
Committee, the CAC Procedural Manual, and any other relevant CAC texts, WHO,
or FAO texts.163 The matter was adjourned for deliberations in the working group
and for a review the next year.
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15.

In 2008, at the 36th session of the CCFL164, a similar situation continued. The
working group failed to reach a consensus. It was suggested that as a consensus
could not be reached, a list of principles or concepts to be taken in to account should
be detailed instead of developing a standard on labelling. CCFL recognized the large
support for this idea and decided to replace the proposed draft guidelines with a set
of recommendations. US opposed this move. Consequently, the CCFL decided to
refer the matter to Step 3 for comments from participants. The significance of this
session is that it opened the doors for the Compilation. The final adopted text is a set
of recommendations as suggested in this session.165

16.

In 2009, at the 37th session of the CCFL,166 demands were made to discontinue
work on this agenda as no progress was being made despite referring the matter to a
set of recommendations. However, many countries felt the need to continue as the
proposed draft recommendations could prove useful over time. CCFL continued
discussion on the proposed recommendations but no consensus could be reached and
the matter was withheld at step 3 for further consideration at the next session.167
Even in 2009, no progress was made on this matter and countries remained divided
on product versus process labelling. Even though CCFL agreed to promote the text
as a recommendation, nothing changed with respect to the ideologies of
participating countries.
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17.

In 2010, the 38th session of the CCFL168 saw the beginnings of the final adopted
Compilation. The discussion primarily focused on the purpose and scope of the
recommendations, and much progress was made. The participants agreed that
different countries had different approaches to labelling and that the CAC
compilations should recognize the same.169 The deliberations at this session
indicated a shift from the earlier stalemates toward an acceptable set of
recommendations.

18.

In 2011, the 39th session of the CCFL170 marked the culmination of a long 18-year
struggle to develop an acceptable set of guidelines for labelling of food derived from
modern biotechnology.171 The members agreed to an amendment of the title to read
“Proposed draft compilation of Codex texts relevant to labelling of food derived
from modern biotechnology.” Argentina expressed reservations on the adoption of
this title; however, the committee accepted it as a working title and decided to revisit
it later. It was agreed that the purpose of the recommendation should read, “the
purpose of this document is only to recall in a single document some important
elements of guidance from Codex texts which are relevant to labelling of foods
derived from modern bio-technology.” The members agreed that a list of the
applicable CAC texts should be made through a hyperlink and there was no
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requirement to provide detail for each of the applicable provisions. This proposal
was accepted to facilitate amendments in future. The delegation also agreed to
include the general guidelines for the term halal,172 and also general guidelines on
claims. Many delegates were of the opinion that as no further questions remained
the document should be advanced to the commission for adoption at step 5/8 in May
2011.

19.

The “Proposed Draft Compilation of Codex Texts Relevant to Labelling of Food
Derived from Modern Biotechnology” was finally adopted at the Commission in
July 2011 at steps 5/8. The Chair of the CCFL suggested a clarification to the
footnote, which provided a definition of “modern biotechnology.” This was
accepted by the members and the draft was adopted at Step 5/8.173

The deliberations reveal the strong standpoints of policy makers around the world with
respect to labelling of food derived from modern biotechnology. Despite the several years,
the CAC finally adopted a set of recommendations. The concerns about the adoption of
alternative options to labelling could not be addressed. Various important sections with
respect to threshold and verification were also not addressed. As countries now have the
right to decide the model of labelling that suits their needs, it is now up to nongovernmental organizations to pursue their demands with respect to the consumer’s right
to information at the national level. The widespread publicity that the consumer’s voice
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had been heard is not true in its entirety. The truth will vary depending on the national
policy.

Because CAC texts are considered as a standard in a WTO dispute, the fact that CAC now
accepts opposing models of labelling with variations could be a source of future
contention, and despite the length of deliberations, the extent to which the CAC code
assists in promoting an international trade decision would probably require a judgement
from the WTO.

3.8

Compilation of Codex Texts Relevant to Labelling of Food Derived from

Modern Biotechnology:

The 2007 session of the CCFL set a deadline of 2011 for finalizing the draft guidelines on
labelling of food derived from genetic engineering. Keeping this deadline in mind, the
2010 session setup a working group, which was largely instrumental in developing the
Compilation. The final adopted recommendation is incorporated in this thesis as
Appendix III.

The working group that met in Brussels, Belgium, in November 2010 was tasked with
exploring the objectives of different delegations with regard to various versions of the
texts being circulated, and to reconcile them in one text, if possible.174 The group focused
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on the original purpose of the agenda item as dictated to the CCFL by the Commission,
which was to “provide guidance on how the fact that a food was derived from modern
biotechnology could be made known to the consumer.”175 The group considered and
discussed the views adopted by member countries in order to understand the objectives
and the rationale behind the positions adopted. After an extensive preliminary discussion,
the working group was further sub-divided into four groups. Each group was asked to
develop a statement on the objectives of a labelling text and the key indicators of success
that such a text would reflect. A general compilation of the objective of a labelling
standard was agreed to as follows:
Articulate guidance based upon existing Codex texts which can inform
member countries national frameworks for the labelling of foods derived
through modern biotechnology (FDMB):
• Providing principles relevant to FDMB within the Codex framework for
labelling all foods.
• Supporting informed choice by consumers
• Enabling different approaches to the national framework supporting the
above176

This objective reveals a general understanding among member countries that there are
different approaches to labelling and that labelling of food derived from modern
biotechnology should be based on prevalent CAC Texts.

Subsequent to establishing the objective, the working group discussed the text that had
been circulating among member countries since 2009. This involved a discussion of the
title of the document, the purpose, and the text. There was no consensus with respect to
the title of the document; however, progress was made with respect to the ‘purpose’ and
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the ‘considerations text’ that was included in the options provided for further discussions
to the CCFL. The participants concurred that there were three possible approaches to the
manner in which the recommendations could be drafted, and their report summarized the
options as follows:
(a) The guidance could make reference to the relevant texts in paragraph 1 of
the Appendix with the addition of the Codex Guidelines for the Production,
Packaging and Labelling of Organic Foods and the Guideline for the
Conduct of Food Safety Assessments of Foods Derived from RecombinantDNA Animals and include reference to particularly pertinent sections.
(b) The guidance could make reference to the relevant texts found in
paragraph 1 (with the addition of the Codex Guidelines for the Production,
Packaging and Labelling of Organic Foods and the Guideline for the
Conduct of Food Safety Assessments of Foods Derived from RecombinantDNA Animals) and include reproductions of the relevant specific sections in
table 1.
(c) All relevant texts could be reproduced in the guidance document.177

Although the three options agreed on the same set of texts to be included, they varied in
the method of their incorporation/presentation in the Compilation. The working group
suggested the above three options to the 39th session of the CCFL when it met in 2011.

Clarity in the purpose and considerations texts proved to be very useful in the final
adoption of the Compilation. The purpose, as indicated in the Compilation, was to
combine in a single document all CAC Texts relevant to the labelling of foods derived
from modern biotechnology and is based on the consideration that there are different
approaches to labelling and that the Compilation does not suggest that FDMB are
different from other foods merely due to the method of production. It also reflects the
understanding among participating members that any national framework for labelling of
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FDMB has to be in accordance to the adopted CAC texts.178

The first text identified by the Compilation is the “Codex General Standard for Labelling
of Prepackaged Food.”179 The text on labelling of FDMB has particularly incorporated
sections 3.1, 3.2, 4.1.1, 4.1.2, 4.2.2, and 7.1. This code deals with the labelling
requirements for prepackaged food. It requires that labelling should be truthful, not
misleading or deceptive; labels should not be confusing or deceptively suggest that the
item is connected with another product/producer. The guidelines also contain mandatory
labelling provisions, as detailed in section 4.1.1 and 4.1.2180 that have been incorporated
into the Compilation. The mandatory provisions require that unless expressly provided, a
label shall contain the name of the food and the true nature of the food. If a CAC Standard
has incorporated a specific name, such a name shall be included in the label, otherwise the
name as indicated in the national labelling legislation should be specified. Section 4.2.2
contains specific reference to FDMB. This section only refers, however, to allergens
transferred in cereals containing gluten, eggs, fish, peanuts, soybeans, milk, tree nuts, and
nut products. The section requires that such ingredients be declared and if it is not
possible to provide adequate information then such products should not be marketed.181

Section 7.1, which deals with optional labelling, states that any information or pictorial
device written, printed, or graphic matter may be included in a label provided that it is not
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in conflict with the above requirements. This section could be interpreted as supporting
positive or negative labels that indicate the presence or absence of GM ingredients in
food. Thus, unless there is the presence of allergens, the Codex General Standard for
Labelling of Prepackaged Food does not require FDMB to be labelled, but if they are
labelled, then the criteria is that it should be truthful, not misleading or deceptive. This
guideline supports either model of labelling provided it meets with the mandatory
requirements contained therein.

The second text stated in the Compilation is the “General Guidelines on Claims”182:
a claim is any representation which states, suggests or implies that a food has
particular characteristics relating to its origin, nutritional properties, nature,
production, processing, composition or any other quality.183

Thus, according to this definition, any declaration of whether a food contains or does not
contain GM ingredients is a claim and must comply with the provisions of this guideline.
According to the Compilation the applicable sections of this guideline are sections 1.2,
1.3, 2, 3.3, 3.5, 4.1 and 5.1 (iii), 5.1 (iv), 5.1(v) and 5.1(vi).184 Section 1 echoes the idea
that a label should be truthful and not misleading or deceptive. It requires that a person
making a claim should be able to justify the same. Section 3.3 and 3.5 prohibits claims
that cannot be substantiated or that give rise to doubt about the safety of similar food or
that could arouse or exploit fear in the consumer.185 Section 4.1 prohibits the use of
meaningless claims that involve the use of comparatives and superlatives. Section 5.1 (iii)
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to (vi) specify claims that could be used provided they are in compliance with national
practices and other guidelines adopted by the CAC. This section also requires that such
claims should not be specifically prohibited by prohibited by Section 3.3 and 3.5. Section
5.1(iv) deals with claims pertaining to religious and ritual preparation (both Halal and
Kosher) requiring that such claims should confirm to the requirements of the appropriate
religious or ritual authorities. Further, it does reference the CAC text on preparation of
‘Halal’ foods.

The provisions of this guideline that are applicable to labelling of food derived from
modern biotechnology provide a basis for using labels, whether positive or negative, on
genetically modified food. Labels have to comply with the above restrictions in order to
be considered as fair claims according to the CAC texts. Thus, labels on GM food,
whether positive or negative, should be truthful, should not create doubts about the safety
of similar food, and should not arouse or exploit fear in the consumer about the safety of
foods derived from modern biotechnology. Labels should not involve the use of
comparatives or superlatives and should not be against other CAC guidelines.

The third guideline that has been incorporated into the Compilation is “Guidelines for the
Use of Nutrition and Health Claims.”186 The Compilation requires labelling of foods
derived from modern biotechnology to be compliant with national policies on nutrition
and health claims supported by sufficient scientific evidence. It also requires that nutrition
and health claims should be truthful and based on General Guidelines on Claims as stated
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above. The guideline has a set of recommendations on the scientific substantiation of
health claims annexed to it. This annexure elaborates the manner in which scientific
studies have to be undertaken and how analysis should be made. Thus any nutrition and
health claims of FDMB should be substantiated on a scientific basis, as required by this
guideline. The prohibitions as stated in the General Guidelines on Claims are also adopted
in the Guidelines for the use of Nutrition and Health Claims.

The fourth text adopted in the Compilation is the “Guidelines for the Production,
Processing, Labelling and Marketing of Organically Produced Foods.”187 Section 1.5
specifically excludes foods derived from the use of genetic engineering from being
certified as organic. This expressed exclusion clearly differentiates certified organic foods
from FDMB.

The fifth text adopted is “General Guidelines for Use of the Term ‘Halal,’”188 which was
included to accommodate the religious concerns of consumers. The purpose is to provide
guidance to producers of FDMB. It lays down the permissible ingredients and the method
of production necessary for genetically engineered food to be certified as “Halal.”

187

Guidelines for the Production, Processing, Labelling and Marketing of Organically Produced Foods,
1999, CAC/GL 32-1999, online : The Codex Alimentarius Commission at s 1.5
<http://www.codexalimentarius.org/standards/list-of-standards/en/>
188
General Guidelines for Use of the term “Halal”, The Codex Alimentraius Commission, 1997, CAC/GL
24-1997; <http://www.codexalimentarius.org/standards/list-of-standards/en/>

76

The sixth guideline incorporated into the Compilation is the “Principles for Risk Analysis
of Foods Safety for Application by Governments.”189 These principles guide member
countries on “risk assessment, risk management and risk communication with regard to
food related risks to human health.”190 The principles stated in this guideline “apply
equally to issues of national food control and food trade situations and should be applied
consistently and in a non discriminatory manner.”191 They provide the scientific basis on
which member countries can develop and implement the approval and marketing of foods
derived from modern biotechnology. Risk analysis is divided into three parts – risk
assessment, risk management, and risk communication. This principle requires that all
three components be treated as interrelated and be applied in a transparent manner. This
principle guides member countries on identification and analysis of certain components of
food.

The seventh CAC text in the Compilation is “Principles for the Risk Analysis of Foods
Derived from Modern Biotechnology.”192 This guideline elaborates the principles for risk
analysis specifically for foods derived from modern biotechnology. It provides guidance
on evaluating foods that lack history of use. The definitions of risk assessment, risk
management, and risk communication are based on the CAC Guideline on “Working
Principles for Risk Analysis for Application in the Framework of the Codex
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Alimentarius.”193 The risk assessment should be in consultation with the risk management
experts and it should involve hazards identification, hazard characterization, exposure
assessment and risk characterization. With respect to risk management, the principle
states:
National government decisions on risk management, including sanitary
measures taken, should have as their primary objective the protection of
the health of consumers. Unjustified differences in the measures selected to
address similar risks in different situations should be avoided.
This presents one of the primary grounds on which mandatory labelling legislation could
be challenged. Mandatory labelling legislation intended to be used as a risk management
policy would be required to establish that its primary objective is the protection of the
health of consumers. It should be justified and applied uniformly across similar scenarios.
Risk management should also take into account economic consequences and feasibility.
All risk analysis should include clear communication among risk assessors, risk
managers, and other interested parties. This principle provides a framework for
undertaking risk analysis on FDMB. It also provides a definition of biotechnology as
stated in the Compilation:

Modern biotechnology means the application of:
In vitro nucleic acid techniques, including recombinant deoxyribonucleic
acid and direct injection of nucleic acid in to cells or organelles. or Fusion of
cells beyond the taxonomic family, that overcome natural physiological
reproductive or recombinant barriers and that are not techniques used in
traditional breeding and selection.194
In paragraph 19, which deals with risk management measures, the principle states that risk
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management measures may include, as appropriate, food labelling conditions for
marketing approvals and post market monitoring. Paragraph 20 states that post-market
monitoring may be justified if there is a need determined on a case-to-case basis. Postmarket monitoring may be undertaken for the purpose of “verifying conclusions about the
absence or the possible occurrence, impact and significance of potential consumer health
effects….”195

These two paragraphs provide the basis on which member countries could justify their
mandatory labelling legislation. Countries are free to label foods derived from modern
biotechnology if they intend to observe their impact on the health of consumers. The
principle does not state how long such labelling could be adopted as a risk management
technique but it provides a basis on which countries intending to adopt a mandatory
labelling approach could do so without sanction from the World Trade Organization.

The eighth CAC text incorporated in the Compilation is the “Guidelines for the Conduct
of Food Safety Assessments of Foods Derived from Recombinant DNA Plants.”196 This
principle is intended to address the safety and nutritional aspects of whole foods derived
from plants that have been modified by modern biotechnology to exhibit new and altered
traits. The safety assessment under this principle is based on the concept of substantial
equivalence wherein foods derived from new plants, including plants that have been
modified by modern biotechnology, are compared to their conventional counterparts that
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have a history of safe use. All intended and unintended effects of the whole food are
considered prior to the commercialization of such foods. The principle requires that
attention be given to new altered hazards and supports the post-market monitoring of such
hazards. In paragraph 6 this principle specifically mentions “The Principles for Risk
Analysis of Foods derived from Modern Biotechnology”197 that promotes “labelling” as
one of the tools for post market monitoring of foods derived from modern biotechnology.
The guideline provides a detailed description of the key areas for conducting a risk
analysis of the new food, including an annexure on the “Assessment of Possible
Allergenicity,” that requires the identification of the new protein and the safety
assessments prior to commercialization.

The ninth CAC text incorporated in the Compilation is the “Guidelines for the Conduct of
Food Safety Assessments of Foods Derived from Recombinant-DNA microorganisms.”198
This principle is intended to address safety and nutritional aspects of foods produced
through the actions of recombinant-DNA microorganisms. Such recombinant-DNA
microorganisms may be present or used in to assist in the productions of foods. This
principle is also used along with the “Principles for Risk Analysis of Foods derived from
Modern Biotechnology”, and in paragraph 7 it also supports labelling as a tool of postmarket analysis to monitor the unintended effects of microorganisms.

The last CAC text incorporated in the Compilation is the “Guideline for the Conduct of
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Food Safety Assessment of Foods Derived from Recombinant-DNA Animals.”199 This
principle addresses the safety and nutritional aspects of foods consisting of, or derived
from, animals that have a history of safe use as sources of food, and that have been
modified by modern biotechnology to exhibit new or altered expression of traits.200 The
principle recommends the approach for food safety assessment for foods derived from
recombinant-DNA animals where a conventional counterpart exists. It recommends the
use of the best scientific knowledge to ensure that the food does not cause harm when
cooked or consumed. The safety assessment is intended to capture the unintended effects
of the food that has been modified by the use of modern biotechnology.

Thus the Compilation attempts to integrate all the relevant texts with respect to the
approval of food derived from modern biotechnology. Even though these texts existed
prior to the Compilation they have been amended to integrate them into the issue of
labelling. Though the Compilation does not support one model of labelling over the other,
it does provide guidance to member countries who wish to adopt labelling legislation. The
scientific basis required for the approval and sale of FDMB along with the restriction that
post-market monitoring should be justified to the extent of perceived risk, provides the
foundation on which a labelling model should be based.

The Principles for Risk Analysis of Foods derived from Modern Biotechnology, which
suggests labelling as a tool for post-market analysis, does not prescribe the duration for
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which labelling would be required. It also does not deal with the kind of information that
could be included in such labels. Even though international agreements and guidelines
provide for discretion to national legislatures, the exact extent to which labelling could be
used as a tool for post-market monitoring should have been addressed by the Compilation.
The Compilation does not address several issues raised during the discussions, such as the
threshold limit, verification techniques, whether there should be product or process
labelling, and what products could be exempt from labelling. The existence of these loose
strings could undermine the efforts made by CAC to provide a panacea to the problem of
labelling of FDMB.

82

Chapter 4: Codex Alimentarius Commission and the WTO

During the initial discussions that established the CAC, the officials and experts
considered protecting the health of consumers and ensuring fair practices in food trade to
be the primary purpose of CAC. They were of the opinion that if all countries harmonised
the food laws and incorporated similar international food standards, the preliminary
purpose of health and fair trade practices would be served.201 During that period many
countries had introduced conflicting mandatory provisions with respect to FDMB, to
minimize risk to consumer health, and CAC sought to remedy this situation by providing
guidelines to promote more uniform standards.

With the Uruguay Round of agreements,202 however, a new milestone was reached in
CAC history. These agreements recognized CAC as an international standard-making
body. The role played by CAC has thus become more important in promoting
international food trade for both the governments and industry. The increased interests in
the formulation of CAC standards, guidelines, and recommendations can be attributed to
the increased awareness of two important functions of CAC. First, CAC supports member
countries by providing guidelines on which national policies can be built. Hence,
developing countries that lack resources to develop adequate food regulatory principles to
ensure public health and promote trade have become aware that CAC guidelines provide
the necessary information. Second, CAC supports consumers and industry alike by
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protecting consumer health and safety and at the same time promoting international trade
in food. Thus, industry and non-governmental organizations have become aware that
CAC guidelines form the basis of food trade and have actively participated in its
deliberations. CAC standards have also been given recognition in the WTO Agreements
as a standard by which disputes over food trade would be resolved.203

Given the economic and trade implications of the CAC guidelines or standards, labelling
of FDMB was one of the most highly debated issue at CCFL and CAC. Elaborate
deliberations about the scope, application, traceability, documentation, verification, and
safety of foods derived from modern biotechnology engulfed the CCFL for 18 years. “The
standard setting process of the Codex Alimentarius has inevitably ended up being
politicized – sometimes to the point of a stalemate.”204 All countries realized the
importance of this issue and wanted to adopt a guideline; however, there was no
consensus on the exact nature of the guideline. The consequences that could emerge at the
WTO from a CAC guideline was partly the reason for the lack of consensus in
determining a standard for labelling FDMB.

Two of the WTO agreements quote CAC standards as a reference point for the settlement
of international food trade disputes. First, the Agreement on Application of Sanitary and
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Phytosanitary Measures205 (SPS agreement) and second, the Agreement on Technical
Barriers to Trade206 (TBT agreement). The overall objective of these agreements is to
prevent national standards and legislation from becoming barriers to trade and to promote
free and fair access to international markets. Article 12 (3) of the SPS agreement
specifically recognizes CAC standards, guidelines, or recommendation as a source of
scientific advice and Article 12(4) states that international guidelines form the basis for
setting import standards for sanitary and phytosaniatry measures. Similarly Article 2.4 of
the TBT agreement recognizes all international standards work including the CAC as
authoritative in determining trade barrier issues.207 This recognition in both the
Agreements above designates the CAC “as a benchmark authority for global standard
setting in the WTO context.”208

Should any dispute arise between member countries regarding the application of the
agreements of the WTO, governments have recourse to the procedures established under
the Dispute Settlement Understanding (DSU).209 Article 3 of the DSU states that the
function of the system is to preserve the rights and obligations of its members under the
covered agreements. The system attempts to clarify the existing provisions of the covered
agreements on the basis of the text of the agreements and any explicit reference included
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in them.210 All requests for conciliation are heard by the Dispute Settlement Board (DSB).

Even though the WTO is not responsible for developing food safety standards it does have
the authority to identify standards that restrict international food trade.211 So, national
standards that are unjustified and act as barriers to the access of international markets can
be referred to the WTO for its review. Some of the issues that will be important in
understanding the role of WTO in labelling of food derived from modern biotechnology
are:




Which WTO agreements apply when labelling requirements and
product- tracing requirements pursue multiple policy objectives.
Whether GM foods are like other products to non GM foods for
the purpose of Article 2 (1) of the TBT agreement and Article III(4) of
GATT 1994.
What the likely impact of labelling and product- tracing
requirements are for the competitive opportunities for GM food with
respect to Article 2 (1) of the TBT agreement and Article III(4) of
GATT 1994.212

It is first necessary to determine which agreement could apply in the event a dispute were
to arise with respect to labelling of FDMB. Second, it is necessary to understand the
possible grounds on which conciliation could be requested by member countries. Third, it
is imperative to determine the WTO’s understanding of the likely impact of labelling of
FDMB on their marketability.
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4.1

Applicable Agreements:

Some of the agreements that could apply to a dispute on labelling of FDMB are contained
in the General Agreement on Tariffs and Trade and two of its supplementary agreements,
the SPS Agreement and the TBT Agreement. The Cartagena Protocol on Biosafety to the
Convention on Biological Diversity213 is also applicable, although to limited extent, as it
has an indirect impact on labelling at the consumer level. It establishes an advance
informed agreement (AIA) procedure to enable countries to make informed decisions
before agreeing to the import of living modified organisms into their territory through
labelling.214

4.1 (a) General Agreement on Tariffs and Trade (GATT)
GATT contains the general obligations of member countries with respect to international
trade, and Article XX of GATT provides limited exceptions to the application of the
general obligations. Article III of GATT215 requires that member countries give importers
the same treatment as those accorded to products of national origin. The WTO holds that
the intent of Article III is to “provide equality of competitive conditions for imported
products in relation to domestic products.”216 Applying this principle, it would not be
GATT compliant to promote FDMB from national producers yet ban imports. However,
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how the WTO would consider a dispute on banning FDMB while allowing imports of its
conventional counterparts would be based on how similar the WTO considered the
categories of goods .

In the Japan – Taxes on Alcoholic Beverages dispute, the European Communities,
Canada, and United States claimed that spirits exported to Japan were discriminated
against under the Japanese liquor tax system. The DSB clarified how “like products” as
contained in Article III.2 would be determined:
“likeness” of products must be examined taking into account not only
objective criteria (such as composition and manufacturing processes of
products) but also the more subjective consumers’ viewpoint (such as
consumption and use by consumers) …. Since consumer habits are variable
in time and space and the aim of Article III:2 of ensuring neutrality of
internal taxation as regards competition between imported and domestic like
products could not be achieved if differential taxes could be used to
crystallize consumer preferences for traditional domestic products…. Even if
imported alcoholic beverages (e.g. vodka) were not considered to be “like”
to Japanese alcoholic beverages (e.g. shochu Group A), the flexibility in the
use of alcoholic drinks and their common characteristics often offered an
alternative choice for consumers leading to a competitive relationship. In the
view of the Panel there existed – even if not necessarily in respect of all the
economic uses to which the product may be put – direct competition or
substitutability among the various distilled liquors, among various liqueurs,
among unsweetened and sweetened wines, and among sparkling wines. The
increasing imports of “Western-style” alcoholic beverages into Japan bore
witness to this lasting competitive relationship and to the potential products
substitution through trade among various alcoholic beverages. Since
consumer habits vis-à-vis these products varied in response to their
respective prices, their availability through trade and their other competitive
inter-relationships, the Panel concluded that the following alcoholic
beverages could be considered to be “directly competitive or substitutable
products” in terms of Article III:2.217
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Thus a “like product” is determined based on characteristics, manufacturing process,
consumer perceptions and preferences, end use, competitive inter-relationship, and
substitutability between the products. The DSB Panel considered the operation of all the
above factors as a whole in determining whether two products could be considered as
“like products.” In “European Communities – Measures Affecting Asbestos and
Asbestos-Containing Products”218 the Appellate Body (AB) of the WTO held that “health
risks” should also be considered in determining “likeness.”

Applying the above test in a comparison of FDMB to their conventional counterparts, the
characteristics, manufacturing process, potential health risks, end use, competitive
relationship with conventional counterparts, consumer perceptions, and preferences could
very well be the determining factors in the event of a WTO challenge.

Further, Article XX(b) GATT219 states the exceptions to Article III; it recognizes the right
of member countries to develop policies that “protect human, plant and animal health and
safety.” A request for conciliation could be made with respect to testing, inspection,
certification, approval procedures, quarantine treatments, sampling procedures, and risk
assessment methods in a regulation with respect to FDMB. In such a case, a country will
have to justify that its regulation of a particular FDMB is required to protect human, plant
and animal health and safety even though the FDMB may be considered as a “like
product”.
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This exception was discussed by the DSB in “European Communities – Measures
Affecting Asbestos and Asbestos-Containing Products Case.”220 In 1998, Canada
requested consultations with the EC with respect to measures imposed by France
regarding the prohibition of asbestos and products containing asbestos, including a ban on
imports of such goods. In 1997, France prohibited the manufacture, processing, sale,
importation, exportation, domestic marketing, possession for sale, offer, and transfer of all
varieties of asbestos fibres, regardless of whether these substances have been incorporated
into materials, products, or devices. Canada challenged the ban on chrysotile fibre and
products containing it. Canada stated that chrysotile fibre was not like amphibole fibres,
the asbestos most hazardous to health, and thereby the ban was not justified.

The AB held that the products were alike because the end uses were the same and they
were substitutes of each other. With reference to exception XX(b) of GATT, the AB held
that.
… there is no requirement under Article XX(b) of the GATT 1994 to
quantify, as such, the risk to human life or health. A risk may be evaluated
either in quantitative or qualitative terms. In this case, contrary to what is
suggested by Canada, the Panel assessed the nature and the character of the
risk posed by chrysotile-cement products. The Panel found, on the basis of
the scientific evidence, that “no minimum threshold of level of exposure or
duration of exposure has been identified with regard to the risk of
pathologies associated with chrysotile, except for asbestosis.” The
pathologies which the Panel identified as being associated with chrysotile are
of a very serious nature, namely lung cancer and mesothelioma, which is
also a form of cancer…221
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The AB held that for the exception of protection of public health to be upheld it must be
proven on scientific basis that there is possible harm to the public.

4.1 (b) The SPS Agreement
The SPS Agreement permits WTO members to apply measures necessary for the
protection of human, animal or plant life, or health.222 Measures that conform to the SPS
Agreement are presumed to be in accordance with GATT provisions. 223 SPS measures
may relate to process and production methods, testing, inspection, certification, approval
procedures, quarantine treatments, sampling procedures, risk assessment methods and
packaging, and labelling requirements related to food safety.224 The measures adopted by
member countries should be based on scientific principles and sufficient scientific
evidence, and should not be more trade restrictive than necessary to achieve the
appropriate level of sanitary and phytosanitary protection.225 Annexure A to the SPS
Agreement suggests that the purpose of the regulation also be considered.

Thus a labelling policy must be justified as a measure to protect against risks from pests
or diseases or food borne risks to human, animal, and plant health and safety and will
need to be decided on a case-to-case basis. Article 5.1 of the SPS Agreement226 states
that:
Members shall ensure that their sanitary or phytosanitary measures are based
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on an assessment, as appropriate to the circumstances, of the risks to human,
animal or plant life or health, taking into account risk assessment techniques
developed by the relevant international organizations.

This article is important, keeping in mind the current Compilation. The Principles for Risk
Analysis of Foods derived from Modern Biotechnology, which is one of the texts in the
Compilation, specifically mentions labelling as tool for post-market monitoring. Given
that the SPS Agreement recognizes CAC guidelines, a mandatory labelling regulation
could only be challenged on grounds of scientific evidence.

Further, the SPS Agreement recognizes the precautionary principle, and Article 5.7
dealing with the treatment of scientific evidence states that:
In cases where relevant scientific evidence is insufficient, a Member may
provisionally adopt sanitary or phytosanitary measures on the basis of
available pertinent information, including that from the relevant international
organizations as well as from sanitary or phytosanitary measures applied by
other Members. In such circumstances, Members shall seek to obtain the
additional information necessary for a more objective assessment of risk and
review the sanitary or phytosanitary measure accordingly within a reasonable
period of time.227

Member countries may choose to adopt labelling regulations based on the precautionary
principle. As stated above228, this principle has been the subject of varied interpretation.
According to Article 5.7, a labelling policy could be adopted based on the precautionary
principle when there is a lack of relevant scientific evidence, based on international
standards, to support the safe use.229 Given this requirement, one can understand clearly
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why CCFL decided to proceed with the matter of labelling of FDMB, despite the lack of
consensus for such a long time. Developing countries that lack resources are dependent on
the scientific principles adopted by CAC, for developing their regulations on approval and
commercialization and management of foods derived from modern biotechnology.
Secondly, even developed countries can use the approved standards to challenge or justify
their labelling regulations.

The DSB considered for the first time Article 5.7 of the SPS Agreement in the European
Commission – Measures concerning meat and meat products (Hormones).230 In this case
the US claimed that the EC measures to ban import of meat and meat products containing
bovine growth hormones (BGH) was inconsistent with Articles III or XI of the GATT
1994, Articles 2, 3 and 5 of the SPS Agreement. The EU invoked the precautionary
principle, since there does not seem to be conclusive evidence that BGH meat is
damaging for human health. The AB ruled that the EU violated article 5.1 of the SPS
agreement, since the measure was not sufficiently based on a risk assessment. The EU has
chosen to keep the ban, and pay trade sanctions to the US and Canada, something the EU
in its turn is challenging, since it claims that it has made sufficient changes to its import
restricting measures.

The AB in this case commented on the use of precautionary principle with foods derived
from modern biotechnology as follows;
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It appears to us important, nevertheless, to note some aspects of the
relationship of the precautionary principle to the SPS Agreement. First, the
principle has not been written into the SPS Agreement as a ground for
justifying SPS measures that are otherwise inconsistent with the obligations
of Members set out in particular provisions of that Agreement. Secondly, the
precautionary principle indeed finds reflection in Article 5.7 of the SPS
Agreement. We agree, at the same time, with the European Communities,
that there is no need to assume that Article 5.7 exhausts the relevance of a
precautionary principle. It is reflected also in the sixth paragraph of the
preamble and in Article 3.3. These explicitly recognize the right of Members
to establish their own appropriate level of sanitary protection, which level
may be higher (i.e., more cautious) than that implied in existing international
standards, guidelines and recommendations. Thirdly, a panel charged with
determining, for instance, whether “sufficient scientific evidence” exists to
warrant the maintenance by a Member of a particular SPS measure may, of
course, and should, bear in mind that responsible, representative
governments commonly act from perspectives of prudence and precaution
where risks of irreversible, e.g. life-terminating, damage to human health are
concerned. Lastly, however, the precautionary principle does not, by itself,
and without a clear textual directive to that effect, relieve a panel from the
duty of applying the normal (i.e. customary international law) principles of
treaty interpretation in reading the provisions of the SPS Agreement.231

The AB acknowledged that Article 5.7 recognized the precautionary principle without an
explicit reference to it. They also recognized members’ rights to use precaution where
there were risks of irreversible harm. However, it stated that the use of the principle alone
was not sufficient to uphold any inconsistencies with the obligations under the SPS
Agreement.

The AB again considered the application of Article 5.7 in Japan – Measures Affecting
Agricultural Products.232 The US challenged Japan for its measures that restricted the
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import of certain agricultural products to prevent the introduction of fire blight, a disease
targeting apples and other fruits. The measures were challenged under the SPS agreement.
The AB ruled that article 5.7 of the SPS agreement is not triggered by scientific
uncertainty, but by insufficient evidence.

The condition of “reasonable period of time” in Article 5.7 indicates that such measures
are temporary.233 There is no fixed period of time mentioned and it would depend on the
basis of scientific evidence present. The Principles for Risk Analysis of Foods Derived
from Modern Biotechnology, adopted by Codex, also requires that risk analysis be
reviewed periodically based on advances in science and technology.234 Applying the
above requirements to the labelling of foods derived from modern biotechnology could be
adopted on a case-by-case basis for a reasonable period of time and it would have to be
reviewed intermittently, or as and when new evidence arose.

4.1 (c) The TBT Agreement
The TBT Agreement encompasses a broader range of domestic regulation. The TBT
Agreement distinguishes between standards that are mandatory and those that are nonmandatory technical regulations. A technical regulation has been defined as follows:
Document which lays down product characteristics or their related processes
and production methods including the applicable administrative provisions
with which compliance is mandatory. It may also include or deal exclusively
with terminology, symbols, packaging, marking or labelling requirements as

233 Ellie Cijvat, Genetically modified organisms and the World Trade Organization, (M Sc. Thesis, IIIEE
Lund, Sweden, 2006) [unpublished]
234
Supra note 192

95

they apply to a product, process or production method.235

Thus any labelling regulation that covers characteristics of the products would be covered
by the TBT Agreement. The TBT Agreement imposes substantive obligations on any
regulation or legislation that meets with the definition of a technical regulation. Some of
the obligations are like treatment to similar products, satisfaction of a least trade
restrictive test, legitimate objective based on a relevant international standard where such
standards exist, or cases where such regulations are required. 236 It is important to note that
both the “SPS and TBT agreements acknowledge the importance of harmonizing
standards internationally so as to minimize or eliminate the risk of sanitary, phytosanitary
and other technical standards becoming barriers to trade.”237

A review of the provisions of the WTO agreements above indicates that the objective of
the labelling policy is very important as it could be the deciding factor in determining
whether the national policy is WTO compliant or not. The vast differences among
member countries with respect to the objective of labelling foods derived from modern
biotechnology has made this issue a fertile ground for future disputes.

The EU labelling regulation, for example, describes one of its purposes as being able to
“ensure that consumers are fully and reliably informed about GMOs and the products,
foods and feed produced there from, so as to allow them to make an informed choice of
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product.”238 In public statements the EU has described the purpose of its overall
regulation on GMOs as including the protection of human health and environment.239
Mandatory labelling requirements with such a purpose may fall under the scope of the
SPS agreement; however, a general labelling requirement with an indirect reference to
food safety cannot be so clearly identified and could lead to confusion.240

Labelling requirements that allow consumers to make informed choices about products to
prevent misleading or deceptive practices or for ethical, moral, or religious concerns
would normally fall under the scope of the TBT Agreement. The issue to be considered in
such disputes will be whether such labelling regulations are consistent with the nondiscriminatory obligations to prevent restrictive barriers to trade and the achievement of a
legitimate objective as detailed in article 2(1) and 2(2) of the TBT Agreement.241 Article
2(2) sets out an indicative list of legitimate objectives that includes prevention of
deceptive practices, protection of human health and safety, animal and plant life health
and safety, and safety of the environment.242 Mandatory labelling legislation with the
purpose of informing consumers would be considered as a legitimate objective under
Article 2(2). However, in the event of a dispute the criteria that the DSB will have to
consider is whether or not such measures are “more trade-restrictive than necessary to
fulfil the legitimate objective.”243
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Given the difference between mandatory and voluntary labelling approaches, the
controversy surrounding labelling of FDMB is bound to persist. By not supporting any
particular model of labelling the Compilation has not addressed this confusion. The WTO
dispute settlement panel will still have to face requisitions for conciliation in disputes of
labelling practices as being discriminatory and restrictive and thereby hindering free and
fair international food trade. The WTO approach for determination on a case-by-cases
basis combined with the political understanding of withdrawal in certain cases has led to
the lack of consistency on how disputes with respect to labelling will be treated.

4.2

Are Foods Derived from Modern Biotechnology Similar to Their

Conventional Counterparts?
Whether FDMB are similar to their conventional counterparts will be relevant to the
labelling. If foods are like the conventional counterparts then the labelling regulations will
be compared to the labelling regulations of the conventional counterparts to determine if
there is a discrimination as contained in Article III of GATT.244

The like products test developed in the Japan Alcoholic Beverages Tax law dispute245 will
be applied to determine if FDMB are similar to their conventional counterparts. Whether
FDMB are like their conventional counterparts, in terms of product properties, nature, and
quality has to be determined on case-by-case basis.
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Consumer preferences in determining whether FDMB are similar to their conventional
counterparts is also another factor identified by the WTO in the European Communities –
Measures Affecting Asbestos and Asbestos-Containing Products Case.246 “Consumer
preferences may be based on perceived environmental, safety, or quality or property of
goods. Such preferences may be or may not be expressed in the physical characteristics of
the product but may relate to its method of processing or production...”247 These
preferences vary over time and also with the amount of information that is available to the
consumer.

The Compilation is based on the consideration that FDMB are not necessarily different
from their conventional counterparts, based solely on the method of production. This
understanding might provide some direction in future disputes at the WTO. The health
risks associated with the product will be a relevant issue to determine likeness based on
physical properties. Hence, scientific justification of a labelling requirement may well
become the primary ground on which labelling of FDMB can be justified.

4.3

Competitive Opportunities:

Competitive Opportunities refers to market conditions. The WTO in “Korea – Measures
Affecting Imports of Fresh, Chilled and Frozen Beef”,248 has dealt with this issue. Article
III(4) of GATT dealing with the “Nation Treatment and International Taxation and
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Regulation ” states
The products of the territory of any contracting party imported into the
territory of any other contracting party shall be accorded treatment no less
favourable than that accorded to like products of national origin in respect of
all laws, regulations and requirements affecting their internal sale, offering
for sale, purchase, transportation, distribution or use.

In this dispute, Australia and US challenged the Korean measures that affected the
importation of certain beef products. The Korean government had adopted measures that
supported their domestic beef industry and Korean agriculture. It also promoted separate
retail distribution channels for imported beef products along with other retail measures
that affected the market of imported beef. The WTO held that, the separate channel was
more trade-restrictive than necessary. “Conditions of competition” includes any condition
that could affect imported goods and favour domestic products.249 The AB at the DSB
found the Korean measures to be inconsistent with the requirements of the Article III(4)
of GATT and hence asked Korea to amend its laws.

Thus member countries have to provide equal market access to both domestic and
imported goods, and thereby any conditions that affect the marketability of imported
goods could be considered a violation of this article. If FDMB are considered similar to
their conventional counterparts, then the requirement of labelling could be challenged as
affecting marketability due to (a) consumer perceptions and (b) increase in costs.
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4.3 (a) Consumer perceptions
Consumer perceptions about the product directly affect the demand for the product.
Consumers do not readily accept FDMB and some of the concerns raised are as follows:
GM food is viewed by many consumers as an undesirable attribute. This
view has been criticized by some scientists and industry members.
Nonetheless, numbers of consumers express wariness of GM food: the
introduction of GM food is not seen to have arisen from the requests of
consumers and does not provide conclusive consumer benefits of improved
quality and safety; GM food is viewed by some to be new, different and
without demonstrated long-term evidence of safe use; its introduction and
use appear to benefit mainly large corporations and farmers and reflect their
interests, rather than the public interest; and its production may introduce
unintended and irreversible genetic changes in the surrounding
environment.250

The requirement for labelling amid this widespread negative perception of FDMB would
directly affect marketability. The crucial factor to be determined is whether, labelling is a
tool to address negative perceptions of consumer or whether labelling creates negative
perceptions about safety of food.251 The AB in the Korea – Measures Affecting Imports of
Fresh, Chilled and Frozen Beef,252 found that labelling indicating that the products were
imported created negative perceptions among consumers and hence affected the
marketability of such products. This was considered to be a violation of Article III(4) of
GATT.253 With labelling of FDMB it is difficult to determine whether labelling creates
negative consumer perceptions or it addresses consumers concerns.

The ability of labelling to impact consumer preferences was recognized by the AB in
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European Commission – Trade Description of Sardines.254 Peru challenged the European
regulation that prevented Peruvian exporters from using the trade description of
“sardines.” According to Peru their export of “sardinops sagax sagax” are listed among
those species that can be traded as “sardines” in the CAC Standard dealing with labelling
and packaging of foods. The European Communities stated that its consumers associated
the term “sardines” exclusively with “Sardina pilchardus” and hence its regulation
restricting the use of the term sardines to “Sardina pilchardus” was justified. The Panel
Report rejected the European Communities claim and the same was upheld by the
Appellant body. The Panel Report stated:
If we were to accept that a WTO Member can “create” consumer
expectations and thereafter find justification for the trade-restrictive measure
which created those consumer expectations, we would be endorsing the
permissibility of “self-justifying” regulatory trade barriers. Indeed, the
danger is that Members, by shaping consumer expectations through
regulatory intervention in the market, would be able to justify thereafter the
legitimacy of that very same regulatory intervention on the basis of the
governmentally created consumer expectations. Mindful of this concern, we
will proceed to examine whether the evidence and legal arguments before us
demonstrate that consumers in most member States of the European
Communities have always associated the common name “sardines”
exclusively with Sardina pilchardus and that the use of “sardines” in
conjunction with “Pacific,” “Peruvian” or “Sardinops sagax” would therefore
not enable European consumers to distinguish between products made from
Sardinops sagax and Sardina pilchardus.255
Accordingly, it is necessary to establish consumer expectations or perceptions objectively.
Given the variable nature of this criteria, this would be difficult to achieve. Thus labelling
regulations have to be justified on scientific evidence in order to withstand any challenge,
as they have the potential to encourage adverse consumer perceptions.
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4.3 (b) Compliance Costs
The other important factor that could affect competitive opportunities of FDMB is the
cost of complying with the labelling requirements. Increased cost due to mandatory
labelling has been cited as one of the factors for adopting a voluntary model of labelling.
The major cost of labelling arises from identity preservation and associated segregation
systems.256 Identity preservation refers to documentation about the source of the food and
segregation systems refers to infrastructure to keep GM food separate from conventional
food. Whether a labelling requirement would increase cost or not remains debatable.
Several studies have indicated different numbers. The EC, however, considers that the
“transmission and retention of information can be largely incorporated into existing
documentary systems for transactions and as such should not imply significant extra costs
for operators and consumers.”257

A number of studies have indicated that the cost of segregation and identity preservation.
Cost of labelling depends on several critical characteristics such as “the threshold level,
the capacity of the industry to comply with requirements, and the public authority’s
capacity to enforce the labeling rules.”258 The cost of labelling ranges from
USD48/person/year to as low as USD3.50/person/year.259 In 2000, the EC commissioned
a study that estimated that the price increase for identity preservation alone ranged from
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6% to 17% in farm-gate prices.260 The studies have been conducted from 2000 to 2006 to
review the feasibility of mandatory labelling model. The criteria for assessments have
varied and so have the location. National studies have been published for Canada,
Australia, New Zealand, United Kingdom, and the Philippines.261 In the United States it
has been argued that segregation system for soybeans and maize could increase the price
of the conventional counterparts by as much as 100%.262 Moreover, identity preservation
and testing would be required to ensure that the foods had been effectively separated, and
such testing could add as much as 30% to the final food product.263

The cost of labelling could affect the competitive opportunities of foods derived from
modern biotechnology in comparison to their conventional counterparts. The above
challenges highlight the various situations for future disputes before the WTO. The
Compilation has not been able to address these concerns, and the complexity of the matter
makes it almost inevitable that they are decided on a case-by-case basis.

4.4

WTO and the “European Communities – Measures Affecting the Approval

and Marketing of Biotech Products”
One of the disputes that considered several concerns raised with respect to the approval
and adoption of foods derived from modern biotechnology is the “European Communities
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– Measures Affecting the Approval and Marketing of Biotech Products.”264 Although this
cases did not consider labelling, it has dealt with several provisions in the applicable
agreements and is relevant to any future disputes on FDMB.

In this case Argentina complained that the European Union laws regarding the approval
and marketing of foods containing GMOs had violated The SPS Agreement, the TBT
Agreement, and provisions of GATT. In its request Argentina asserted:
1. The existence of the alleged moratorium is a violation of the SPS rules
against “undue delay” in SPS agreement approval procedures;
2. Failure to notify the moratorium as an SPS measure is a violation of SPS
agreement rules on transparency of rule making and notification of domestic
SPS measures to the WTO SPS committee;
3. The EC [European Commission] and EC [EU] member states failed to
publish risk assessments on the likelihood of harm resulting from biotech
products as required by article 5.1;
4. The alleged moratoria are maintained without “sufficient scientific
evidence” in violation of article 2.2;
5. By regulating biotech products, such as genetically engineered seeds,
more strictly than biotech processing agents, such as enzymes used in food
manufacturing, the EC violates article 5.5, which seeks to ensure that WTO
agreements apply SPS measures indiscriminately to domestic and imported
products “in comparable situations.265

Australia, Brazil, Canada, India, Mexico, New Zealand, and US requested to join the
consultations. A panel was set up, and the EC responded by denying the existence of a
moratorium. With respect to the actions of some member countries it stated that such
measures were provisional and permitted under Article 5.7 of SPS Agreement.266 The
Panel rejected this claim and stated that a de facto moratorium had in fact existed and this
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had unduly delayed the approval of several products derived from modern biotechnology.
Further, the provisional measures as detailed in 5.7 required that risks be based on the
assertion that there is insufficient scientific evidence to support acceptance. It stated:

The language in Article 5.7 does not exclude the applicability of all other
SPS provisions simply on the basis that the measures in question are
provisional. The starting point for an analysis of an SPS measure is Article 2.
It establishes basic rights and obligations of the Members with respect to
their SPS measures. Such measures must be based on scientific principles
and must not be maintained without sufficient scientific evidence. Whether
the measures are provisional or not is beside the point.267
The Panel held that there should be scientific evidence in risk assessment that warrant
safety measures whether such measures are provisional or not. The Panel went on further
to review the adoption of Article 5.5 of the SPS Agreement in the EU members. It
reiterated the need for scientific evidence to justify the regulation of biotech products,
such as regulating genetically engineered seeds, more strictly than biotech processing
agents, such as enzymes used in further food manufacturing processes. The Report stated:

When the European Communities’ own experts unambiguously find that
there is no evidence to show that these products are unsafe, and the member
States nevertheless ban the products and maintain those bans in the face of
further scientific advice that such bans are groundless, this cannot be
characterized as anything other than a complete disregard or determination to
ignore such opinions and advice. When this is done on a selective basis that
bears no relationship to the actual risks involved, the conclusion is
inescapable that the resulting measures give rise to a violation of Article 5.5.

In brief, the Panel concluded that the de facto moratorium and 24 product-specific
measures had caused undue delay. With respect to the safeguard measures adopted by
member countries, the Panel ruled it to be incompatible with Articles 5.1 and 2.2 of the
267
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SPS Agreement because the measures were not based on risk assessments satisfying the
definition of the SPS Agreement and hence could be presumed to be maintained without
sufficient scientific evidence. The European Communities accepted the Panel Report and
requested for time to implement findings. On 19 March 2010, Argentina and the European
Union notified the DSB of a mutually agreed solution. The parties agreed to establish a
bilateral dialogue on issues related to the application of biotechnology to agriculture. 268

There were several important issues that were not referred to in this dispute, such as
whether FDMB are safe, whether they are to be considered “like products,” or whether
member countries can design their own risk assessments. The labelling of FDMB was also
not considered, as it was not the subject of this dispute.269 Even though these are very
important concerns it is difficult to make a generalization and would have to be
determined on a case-by-case basis (Compilation, however, has addressed the issue of
standardization of risk assessment procedures). The above case highlighted the role
played by scientific evidence and applying the same to labelling will ensure that scientific
evidence is a crucial factor in determining the validity of a labelling approach.

The Compilation has reiterated the significance of science and has incorporated into a
single text all the texts that member countries would need to consider to develop a
labelling policy. Even though the Compilation recognizes labelling as a tool of postmarket monitoring, it is necessary to be able to justify the perceived risk on scientific
grounds. It is interesting to note that there have been no discussions about the threshold
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limit or about verification at the WTO – some of the concerns that remained unaddressed
even in the Compilation. The nature of the problem along with opposite political
perceptions has left the issue of labelling of FDMB as a minefield to be defused on a caseby-case basis.
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Chapter 5: Models of Labelling
5.1

Background

The complex discussions at CCFL and CAC revealed the vast differences in the
perception and regulation of genetically modified food between countries. Below is a
summary of some of the policy considerations and the options that have been adopted by
countries around the world. The complexity of the problem is compounded by the fact
that there are variations within the options that have been summarized below.270
Policy Questions
How are genetic engineering,
genetic modification, or
biotechnology defined?
Is program voluntary or
mandatory?

Which products are covered by the
policy?
Which ingredients are covered?

When are labelling requirements
triggered?

How are products made from
animals fed with GM inputs
handled?

Some Policy Options
(a) Broadly
(b) By specific techniques used
(a) Voluntary for non-GMO and/or
GMO
(b) Mandatory for GMO
(c) Mandatory for GMO and nonGMO
(a) All food products
(b) Only key food products
(c ) Only certain food categories
(a) All ingredients
(b) Only most important ingredients
(c)All ingredients except
preservatives, additives, etc.
(a) X% of product is GM
(b) Most important ingredients are
GM
(c) Important characteristics are
altered
(a) Labelling required if feed is GM
(b) Labelling not required if feed is
GM
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How are restaurant, take-out, bulk,
and institutional foods handled?

What label statements must/can be
made?

How are companies required to
verify GM status?

Can non-GMO labelling be used on
products where there are no GM
alternatives?

(a) Included in labelling
requirements
(b) Excluded from labelling
requirements
(a) Does contain GMOs (genetically
modified)
(b) May contain GMOs (may be
genetically modified)
(c) Non-GMO
(d) Does not contain GMOs
(a) Self-certification by seller is
acceptable
(b) Testing
(c) Third-party certification
(a) Yes
(b) No

Several food crises in Europe in the 1990s in Europe created a general mistrust among
consumers about the regulatory framework and safety of genetically modified food.271
This channelled the development of legislation to regulate genetically modified food in
Europe. The lack of a similar food crisis in North America contributes to the approach of
regulations for the approval and sale of FDMB in this continent. The EU has adopted a
mandatory model of labelling, whereas the US and Canada have adopted a voluntary
model of labelling of foods derived from modern biotechnology. The mandatory model
adopted in the EU requires tracing and labelling from ‘farm to fork’. The voluntary
labelling model is based on the principle that FDMB are generally regarded as safe due to
the fact that they undergo extensive tests during its development and approval.

As discussed above, labelling proposes to inform the consumer about the product’s
271

Supra note 1 at 541

110

unobservable nature and characteristics. It is an important tool that has a decisive impact
on consumers and hence is sought to be thoroughly regulated. Whether a product contains
genetically modified ingredients is impossible to determine without conducting
verifications tests. Labelling has been considered a technique to deliver such information
to the consumers. The impact of labelling has been summarised as below:
Labeling affects the entire supply chain for food products. It requires
definition of the attribute to be labeled (i.e., what is a “GMO”?) and
segregation of products with and without the characteristics throughout the
supply chain from seed inputs to the supermarket shelf. Because of this
effect, labelling policy can be, and is even more frequently perceived to be,
a Trojan horse bearing a broader policy and attitude toward the acceptance
of GMOs in food products.272

The different opinions on whether this information should be made available to
consumers have provided us with two alternative methods of labelling, mandatory and
voluntary. This chapter analyzes and compares the mandatory labelling model, with
specific reference to the United Kingdom, with the voluntary labelling model, with
specific reference to Canada.

5.2

Mandatory Model and Its Adoption in the European Union.

In the European Union, mandatory labelling is based on the belief that consumers have a
“Right to Know.” Article 27 of The Treaty of Amsterdam 273 sought to amend Article
129(a) of The Treaty Establishing European Union,274 in 1997 to give consumer
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protection a legal status. The Amended Treaty Establishing the European Union in Article
153 provides the basis for the “Consumer’s Right to Know” in the EU. The Article states:
In order to promote the interests of consumers and to ensure a high level of
consumer protection, the Community shall contribute to protecting the
health, safety and economic interests of consumers, as well as to promoting
their right to information, education and to organise themselves in order to
safeguard their interests.275
The above Article directly addresses the consumer’s right to information and education
and forms the basis of the “Consumers Right to Know” in the EU. This right to
information has been the foundation for the tracing and labelling legislation in the EU.
The Europa, in its summaries of legislation writes, “Information is the deciding factor for
consumers when making their choices and affects both consumer interests and their
confidence in the products and services within the internal market.”276 This understanding
indicates the belief that providing the necessary information to consumers could enhance
the confidence of consumers about the market. A survey called “The Europeans and
Biotechnology 2010”277 commissioned by the EC, monitors the acceptance level of
genetically modified food and reasons for the lack of acceptance among consumers.

The 2010 survey indicates a marginal decline in the support of GM food, barring
fluctuations between 1996 and 2010.278 One has to also consider that the composition of
the EU has changed over the years and that this has had an impact on the results.
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According to the survey the primary factor deciding the support or opposition of
genetically modified food is the “issue of safety.” The report states 279
The perceived safety deficit suggests that the risk assessment for GMOs in
place according to EU rules is not considered valid. It could also be
interpreted as an entrenched attitudinal association between GM food and a
lack of safety, notwithstanding institutional efforts to demonstrate the
opposite.

The failure in communication, as indicated above, is very interesting and relevant to the
debate about whether mandatory labelling is sufficient to provide the necessary
information to consumers. Those who oppose the mandatory labelling model believe that
labels do not provide sufficient information for consumers to make an informed choice.
Genetic modification involves complex technology that is difficult to be reduced to a
label.

The issue of safety of some GMOs has caused six countries in the EU to ban the use and
sale of genetically modified products. This ban has been evoked under the “safeguard
clause” in Article 23 of Directive 2001/18/EC.280 The six countries are Austria, France,
Germany, Greece, Hungary, and Luxembourg. Italy is contemplating a ban on GM crops
but has not done so formally.281 Directive 2001/18/EC refers to the Directive of the
European Parliament and of The Council of 12 March 2001 on the deliberate release into
the environment of genetically modified organisms.282 Article 23, referred to as the
“safeguard clause,” permits member countries to provisionally restrict or prohibit the use
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and sale of genetically modified organisms if there is a sufficient scientific evidence of
risk to human or environmental health.283 An analysis of the provisional ban of GMOs in
the above six countries is beyond the scope of this thesis.

The primary Regulation of the EU that forms the basis of the tracing and labelling
legislation in England is the EU Traceability and Labelling regulation 1830/2003284 and
its subsequent amendment through Directive 2001/18/EC.285 This Regulation sets out the
requirements for a document audit trail to account for and identify approved GM products
throughout the marketing chain. This Regulation came into force in April 2004 and was
adopted after nearly two years of intense deliberations.

This Regulation along with the EU Food and Feed Regulation 1829/2003,286 which
creates a specific harmonized procedure for the scientific assessment and authorization of
GM food and feed products, promotes centralized regulation for the approval and
labelling of GMOs in food and animal feed. As the above two rules were adopted by
regulation it does not require national implementation.287

The definition of GMO is contained in Directive 2001/18/EC288 in Article 2(2) as follows:

Genetically modified organism (GMO) means an organism, with the
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exception of human beings, in which the genetic material has been altered in
a way that does not occur naturally by mating and/or natural
recombination.289
Thus any organism in which the heritable characteristics are altered by the use of
techniques such as recombinant nucleic acid techniques (inserting nucleic acid molecules
produced outside an organism into any virus, bacterial plasmid, or other vector system)
and their incorporation into a host organism in which they do not occur naturally, by
methods such as micro-injection, macro-injection, and micro-encapsulation, or cell fusion
that do not occur naturally290 is defined as a genetically modified organism.

This definition forms the basis of all regulation of food containing GMO and FDMB. It is
is similar to the Compilation. In the Compilation, “modern biotechnology” is defined as:
“Modern Biotechnology” means the application of: i) In vitro nucleic acid
techniques, including recombinant deoxyribonucleic acid (DNA) and direct
injection of nucleic acid into cells or organelles, or ii) Fusion of cells beyond
the taxonomic family.291
The definition adopted by the EU is more elaborate on the techniques; however, the
underlying idea is of fusion of nucleic acid molecules that does not occur naturally. The
European Food Safety Authority (EFSA) is the centralized body responsible for the
implementation of Directive 2001/18/EC.

Regulation (EC) No 178/2002292 lays down the general principles for the establishment of
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the EFSA. The EFSA adopts harmonized procedures for the scientific assessment and
authorization of genetically modified food and feed products. It is this centralized body
that is in charge of conducting the risk assessment and developing the risk management
policy. The Regulation requires that “risk assessment” be based on “available scientific
evidence and undertaken in an independent, objective, and transparent manner.”293 This
article incorporates the requirements of the Compilation with respect to risk assessment.

The “Precautionary Principle” has been recognized in this regulation. Article 7,294 it states
that precautionary measures based on identifiable possible harm with scientific certainty
may be adopted on a provisional basis. This Article recognizes the commitment of
member countries to the SPS Agreement. It requires that such provisional measures
should not restrict trade, and that economic and trade consequences should be considered
prior to implementing such precautionary measures. This incorporation of the
requirements of the SPS Agreement into this regulation could help justify any labelling
requirement in the event of a WTO challenge.
Further, Article 13(e)295 states to “promote consistency between international technical
standards and food law while ensuring that the high level of protection adopted in the
community is not reduced.” This Article specifically recognizes international standards
and recommends their incorporation into existing standards. With the Compilation stating
that member countries could choose a model of labelling so long as its criteria for risk
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assessment and risk management are based on scientific principle (this is also specifically
stated in the European Union Regulation (EC) No 178/2002), there seems to a be a
consistency between the Compilation and the EU Regulations on risk assessment and risk
management, at least at the theoretical level. There could, however be challenges based on
the interpretation of scientific evidence used to justify precautionary measures such as
labelling.
EU Traceability and Labelling regulation 1830/2003296 sought to address the concerns
about the lack of information to enable labelling of genetically modified food. The
fundamental belief underlying the labelling requirements is the belief in scientific
uncertainties or the possibility of unintended effects after approval.297 The preliminary
sections of the Regulation 1830/2003 summarizes the purpose:

Traceability requirements for food and feed produced from GMOs should be
established to facilitate accurate labelling of such products… so as to ensure
that accurate information is available to operators and consumers to enable
them to exercise their freedom of choice in an effective manner as well as to
enable control and verification of labelling claims. Requirements for food
and feed produced from GMOs should be similar in order to avoid
discontinuity of information in cases of change in end use.298
This Regulation applies to both food and animal feed, with the purpose of providing
consumers with adequate information to make an informed choice. Its objective is to
provide a framework for traceability and labelling of food and feed containing genetically
modified ingredients, to enable post-market monitoring on health and environment.
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In order to enable tracing, all approved genetically modified organisms will be provided
with unique identifies (Article 8), and all producers, processors, and suppliers shall ensure
that documentation of such unique identifies are properly maintained and transferred. The
labelling provision specifies the language to be used on labels and states that any product
with more than 0.9% GM ingredients should be labelled. The 0.9% margin is for
adventitious or technically unavoidable traces of GM ingredients. The regulation also
empowers member countries to decide on procedures for inspection and control measures.
The member countries can also lay down penalties for infringement of the regulations.299

Further, with respect to the products covered under the GMO regulations in the EU,
Article 12 of Regulation EU Food and Feed Regulation 1829/2003300 states that the
labelling requirement applies to “products which are to be delivered as such to the final
consumer or mass caterers ….which (a) contain or consist of GMOs; or (b) are produced
from or contain ingredients produced from GMOs,”301 that are above the threshold limit.
Article 13.2(d) provides for labelling if the GM food “gives rise to ethical or religious
concerns.”302 This provision indicates that labelling is decided not only on scientific basis,
but it keeps in mind consumer perceptions. As discussed, consumer perceptions are also
considered by the WTO in determining whether a labelling standard amounts to
restrictive trade practice.

Thus, any product that is sold in the EU that has GM ingredients of more than 0.9% will
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have to be labelled as such in the ingredients list. If foods are derived from GM plants, the
regulations require labelling even though there are no traceable GM contents, for
example, GM vegetables. However, there are some exceptions to this general requirement
of labelling and they include refined sugar, vegetable oil, or such products where there is
no DNA or protein resulting from the genetic modification present in the product. These
labelling requirements also associate tracing and documentation to enable labelling. 303 It
has been said that “although other countries have adopted mandatory labelling for GM
food, no regulations have been as sweeping as those of the EU.”304 Even though the
Regulations above seek to centralize the approval and labelling requirement to enable
harmonization, the implementation is at the national level.

The Regulations and Directives detailed above deal with positive labels or labels
indicating the presence of GMO. In practice however, due to the negative considerations
that consumers have about GM ingredients in food, some producers wish to label their
products as “GMO Free”. This is referred to as negative labelling. Negative labels have a
significant impact on the market “the adoption of negative labels can create significant
niche markets,…..a no-GMO label might be interpreted as implying that non-labeled
foods are harmful.”305 Thus the use of Negative Labels has also received significant
attention.
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The EU Regulations do not specify any requirements for negative labelling and it is up to
the national legislatures to develop policies on negative labelling.306 All that is required
according to the EU Regulations is that labels should not be misleading. Some member
states such as Germany and Austria have gone beyond the EU Regulations and provided
national laws or provisions to allow for the use of “GM-free” labelling. In June 2012, a
decree on voluntary labelling came into effect in France on “GM Free” labelling.
According to the decree to be able to use the “GM Free” label, there must be less that
0.1% of GM content in the food.307 Hence there are three kinds of labelling in France less
that 0.1% which could be labelled GM Free, 0.1% to 0.9% which does not require any
labelling and above 0.9% which requires labelling as containing genetically modified
ingredients.308 However, this decree is applicable to GM food produced within France and
not for imports.309 This limitation further complicates the labelling requirements as there
will be products imported into France on which there are no requirements to be labelled
“GM Free” except that the GM ingredients can not be more than 0.9%. Germany and
Austria are said to have similar provisions, while Netherlands has banned “GM Free”
labelling.310
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The variations to labelling of genetically modified food even with in a centralised
authorisation regime such as of the European Union, is a good indication of the
complexity and near impossibility of developing a harmonised policy for labelling
genetically modified food. An example of a labelling in EU is seen below:

311

5.2 (a) Labelling of Genetically Modified Food in England
Labelling legislation in the United Kingdom is based on Genetically Modified Organisms
(Traceability and Labelling) (England) Regulation 2004.312 This Regulation in turn is
based on Regulation (EC) number 1830/2003313 and Directive 2001/18/EC314 discussed
above. It has adopted most of the provisions of Regulation 1830/2003 and details
specifically the procedures for inspection and control measures. It also enumerates the
penalties for infringement of regulation 1830/2003 and Directive 2001/18/EC.
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The Regulation provides for the appointment of inspectors and details their powers to
enter, carry out tests and inspections, take samples or possession of products, conduct
enquiries, require production of information in computerized form in order to investigate
or inspect the implementation of the EFSA’s decision with respect to approval and
labelling of foods containing genetically modified organisms.315 If the inspector is
satisfied that the food or feed containing genetically modified organisms was not being
labelled appropriately, he may serve a notice in writing prohibiting the sale of the product
in the market. He may also require the product to be removed from the premises and
labelled according to the labelling guideline as stated in Regulation 1830/2003. The
English Regulation also specifies offences in sections 8, 9, and 10. Section 11 prescribes
the penalties for a summary conviction of imprisonment for a term not exceeding three
months, or a fine, or both. The Regulations dealing with tracing and labelling
requirements for animal feed are similar to the labelling of FDMB.316

5.2 (b) The European Court of Justice and genetically modified food
The European Court of Justice (ECJ) is the guardian responsible for interpreting the EU
Regulations and it has ruled on the Regulations governing FDMBs sated above. Some of
its decisions are detailed below to better understand how the principles underlying the
labelling of FDMB are regulated in the EU. The cases highlight how the underlying
principles governing FDMB in EU are interpreted by the ECJ.
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Gowan Comércio Internacional e Serviços L v Ministero della Salute317
Mandatory labelling requirements are based on the general belief there is a possibility of
unintended consequences due to the adoption of GM food and hence precaution is
necessary. The ECJ, Court of the Second Chamber in “Gowan Comércio Internacional e
Serviços L v Ministero della Salute”, decided on the extent to which the precautionary
principle and proportionality may be applied in the EU. This case is significant given the
fact that labelling of genetically modified foods has to be justified on the basis that it is a
provisional precautionary measure adopted proportionate to the risk identified. Even
though this case does not specifically deal with the issue of labelling, it is relevant
because it has clarified the extent of application of the precautionary principle and
proportionality.

The facts of the case are as follows: Gowan acquired DowElanco Europe - a company
producing a fungicide called “fenarimol”

and pursued its initial application for an

authorisation of sale of fenarimol for a period ten years and for an extensive market.
Gowan received an initial approval for ten years for unrestricted use. Subsequently, there
were reports of endocrine disruption amongst fish due to fenarimol, though there was no
scientific certainty. Gowan was informed of this and it amended its application by
lowering the time period to seven years and reducing the market coverage. However, the
company was informed that its approval was only for eighteen months with very limited
market coverage. Gowan, submitted before the Regional Administrative Court of law in
Italy that the restrictions on permitted use and reduction of the time period were
317
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unjustified on the basis of the initial assessment procedure. The matter was referred to the
ECJ. The EC stated that there was a study indicating an impact on the endocrine systems
on fish. The study was conducted by Council of Agricultural Ministries; however, the
Council of Agricultural Ministries had not made any definitive decision about safe use.318
Italy had enacted two directives based on the study, which ultimately led to the reduction
in the time period as well as permitted use of fenarimol.

The ECJ, dismissed the objections of Gowan and held that the effects fell under the
assessments of harmful effects on human and animal health. The ECJ held that the
commission must be allowed a wide discretion in appraising complex scientific
assessments. In dealing with the scope of the precautionary principle the it stated that
there was some scientific uncertainty regarding the assessment of the effects on the
endocrine system.319 The ECJ also examined the work of the Standing Committee of the
Council of Agricultural Ministries and the EC and held that the EC had not erred in
applying the precautionary principle, even though no definitive decision of impact on
health was made at the Council of Agricultural Ministries.

The ECJ explained that since precautionary principle is an integral part of the decision
making process leading to the adoption of measures to protect human and animal health
and environment it could also find application within pre-market approval system. This
appears to be the first time the precautionary principle has been expressly recognized as a
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risk management instrument.320 With respect to proportionality the Court concluded that
given the concerns on the subject the measures restricting the use of fenarimol was
suitable for achieving the purpose of the objective. The ECJ held that there was no
outright ban and that the Company could apply for renewal and hence found the measures
proportional.321

As a result of this analysis the ECJ seems to have lowered the evidentiary threshold that
warrants precautionary action. All that the Court considered sufficient in this cases was
identified scientific uncertainty on the basis of which it upheld the Italian directive.322

Monsanto SAS v Ministre de l'Agriculture et de la Peche323
This is another landmark decision, the ECJ nullified the French ban on a GM crop –
MON 810. Between 2007 and 2008 France adopted a series of decrees that banned the
sale, use and cultivation of MON 810 maize. MON 810 maize was authorised for use as
seeds for the purpose of planting and was notified as an existing product in accordance
with the conditions set out in Article 20 of Regulation 1829/2003324(dealing with status of
existing products). The maize was subsequently a subject of a pending application for
renewal of authorization. The ECJ held that under such circumstances the genetically
modified organism may not have their use or sale suspended.
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The ECJ also considered the ‘Emergency Measures’ clause in Article 34 of Regulation
1829/2003.325 It stated that Member States have to establish the existence of a clear and
serious risk to human, animal or environmental health along with the emergency in order
to be justified under this article. The court stated that the expressions “likely” and
“serious” risk must be understood as referring to a significant risk that clearly jeopardises
human, animal or environment. That risk must be established on the basis of new
scientific evidence. That would justify member countries adopting emergency measures.

Finally, the ECJ held that in light of the overall scheme adopted in Regulation 1829/2003,
the ultimate responsibility lies with the EC and the Council of Agricultural Ministries to
determine the safety and adoption of GM food. The court held that France was not able to
justify its ban and invalidated its moratorium as
“purely hypothetical approach to the risk, founded on mere assumptions
which have not yet been scientifically verified. On the contrary, such
protective measures, notwithstanding their temporary character and even if
they are preventive in nature, may be adopted only if they are based on a risk
assessment which is as complete as possible in the particular circumstances
of an individual case, which indicate that those measures are necessary.”326
This case is of significance given Italy’s approach to approving genetically modified
crops within its national boundaries. It also indicates the extent of centralised control
within the European Union on approval and marketing of genetically modified organisms.
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Karl Heinz Bablock and Others v Freistaat Bayern327
This is another landmark judgement the Grand Chamber of the European Court of Justice,
which considered the impact of unintentional and adventitious presence of genetically
modified ingredients in honey. Pollen from genetically modified plants which were no
longer capable of re-producing was found in honey from an apiary which was located
about 500m from a field in which MON 810 Maize was being grown on an experimental
basis . The court considered the following questions:




Does the pollen constitute a genetically modified organism according Regulation
1829/2003?
What is the scope of Article 2.10 of Regulation 1829/2003?
Whether the labelling threshold would apply as an analogy to articles 3(1) and
4(1) of Regulation 1829/2003 dealing with presence of unauthorised genetically
modified ingredients in food?328

The facts of the case are as follows: In 1998 Monsanto Europe obtained authorization to
place genetically modified 810 maize on the market. The cultivation of this maize was
prohibited in Germany and placed under provisional suspension. Freistaat Bayern owned
various plots of land on which MON 810 maize was being cultivated for research
purposes. About 500 meters from him Mr. Bablok, an amateur bee keeper produced both
honey and pollen for sale. In 2005, the DNA of MON810 maize was detected in the maize
pollen harvested by Mr. Bablock. The Bavarian Administrative Court held that the
apicultural products in question are no longer marketable or fit for consumption as they
had been subjected to a “material interference”. The court further explained the meaning
of “material interference” with the product. It stated that contamination by pollen from
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MON 810 strain of maize made the product GM food and hence required authorization by
article 4(2) of Regulation 1829/2003 and be labelled as GM prior to being placed in the
market. The court also held that the pollen from the maize was an organism within the
meaning of article 4.2 of Regulation 1829/2003, even though it had lost its inability to
replicate itself, it could still act as a male gamete under natural conditions and transfer
material to female gametes and hence was a GMO329

The ECJ considered the above three questions and held that the pollen did not constitute a
GMO within the article 2.4 of Regulation 1829/2003. It stated that as the pollen had lost
its ability to reproduce and was totally incapable of transferring its genetic material it
would not come under the definition of GMO in Regulation 1829/2003.

To the second question the ECJ held that article 2.1, 2.10, 2.13 and article 1(c) of
Regulation 1829/2003 established the general principles and requirements of food law.
The Grand Chamber held that that products such as honey and food supplements
constitute ‘food’ under Article 2.1 of Regulation 1829/2003, because they were produced
from MON 810 maize flowers which contained GMOs. The ECJ held that despite the fact
that pollen was not considered a GMO, honey was considered as food containing
ingredients produced from genetically modified organisms as it was produced from the
MON810 Maize flowers (process of production involved GMOs). The Court held that this
classification may be made irrespective of whether contamination of the substance in
question was intentional or unintentional.
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To the third question the ECJ held that article 3(1) and 4(2) must be interpreted as having
an implied obligation to authorise and supervise food stuff. Article 4(2) required specific
authorisation before food containing genetically modified organisms could be placed in
the market. The ECJ held that the threshold of 0.9% that was permitted for labelling could
not be applied by an analogy to such an obligation to authorize and supervise. This
indicates that there is a zero tolerance for the presence of unauthorised GMOs in food,
even though such presence was accidental. Thus any GMO has to approved by the EFSA
before it can be placed in the market and the threshold level is not applicable to an
unapproved GMO. This case has far reaching significance as it laid down that the
presence of GMOs whether intentional or unintentional would need to be approved and
labelled according to the EU regulations.

5.3

Voluntary Model and its adoption in Canada:

The voluntary model of labelling permits food producers to choose whether to label their
products as containing GM ingredients or not. The voluntary labelling regulations
determine the framework of what will constitute GM or non GM, how a label regarding
the presence or absence of GM contents need to be indicated if producers choose to label
their products. The voluntary model has been generally adopted in countries where there
is widespread acceptance of GM food. US and Canada are amongst the leading producers
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of FDMB and consider the food to be safe as it is approved on the basis of the principle of
substantial equivalence.330

Health Canada and the Canadian Food Inspections agency (CFIA) are the two agencies of
the government that share the responsibility of approving labelling and implementing the
policies regarding GM food. Health Canada’s responsibility for food labelling falls within
the department’s mandate to safeguard health and safety while the CFIA leads the Federal
program to develop general food labelling policies and regulations.331 As stated on its
website the “CFIA is responsible for protecting consumers from mis-leading labels and
fraud with respect to food labelling, packaging and advertising.”332
The Health Canada defines GM food as,
food derived from an organism that has had some of its heritable traits
changed. This can involve:



Traditional breeding techniques of crossbreeding.
Using chemicals or radiation to alter the genetic make-up of the organism's
cells in a process called mutagenesis.
 Applying recombinant DNA or genetic engineering techniques - for
instance, introducing a gene from one species into another species.333
This definition includes both traditional breeding techniques and biotechnology
techniques. So any new food would come under the purview of Health Canada if its
genetic makeup has been altered. Such GM food is termed as “Novel Foods” in Canada.
The Canada Food and Drugs Act334 and its Regulations govern the adoption of Novel
330
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Foods in Canada. The manufacturer or importer of the Novel food who wishes to sell or
advertise the food in Canada, must submit an application to Health Canada for a premarket safety assessment, as per the provisions of Division 28 of Part B of the Food and
Drugs Regulations335 also known as Novel Food Regulation.

Detailed information about the food products, testing, development and qualities of the
food has to be supplied to Health Canada on their guidelines. Health Canada reviews the
application by conducting a full safety assessment of the product which involves a
rigorous scientific assessment by Health Canada’s evaluators. Once the evaluation of the
product is complete, a proposal is prepared which is further reviewed by senior members
in the Food Directorate and a decision is made on approving or dis-approving the
product.336
The pre-market safety assessment of genetically modified food is based on the “Principle
of Substantial Equivalence.”337 Application of the concept is not a safety assessment per
se, but helps to identify similarities and differences between the existing food and the new
product. The new food is also subject to further toxicological investigation. Substantial
equivalence is a starting point in the safety evaluation, rather than an endpoint of the
assessment.338

If the product is approved, at this stage other regulatory approvals for environment and
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feed safety is sought. Subsequent to the approval on all fronts, a letter of no-objection is
sent to the product developer by Health Canada. This letter could outline any restriction or
requirement as deemed necessary. It is here that any notification for labelling will be
made.

The mandatory labelling adopted in the EU is based on the fundamental belief that the
consumer has a right to know, what is in his food. There is however, no such
corresponding statutory right in Canada. While Article 19, of the Universal Declaration of
Human Rights339 speaks of a broad right to information, it has been adopted to a limited
extent in Article 2 of the Canadian Charter..340
.
The changes in global climate have brought to the forefront the link between Human
Rights and Environment. In 1994, a “Declaration of Principles on Human Rights and the
Environment”, was proposed.341 Although no draft was not adopted could such a
declaration require mandatory labelling of FDMB? Even though it may be argued that
consumers are not sure of the long term effects of consumption of FDMB, there has been
no identifiable definite risk caused due to the adoption and consumption of FDMBs.
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FDMB are approved based on extensive scientific testing and are considered safe.
Countries with voluntary labelling treat it as unfair trade practise to require labelling.342
Given these considerations it might be difficult to substantiate that consumers have a legal
"right to know" when there is no law that states that they do.

The problem of labelling genetically modified foods without misleading the consumers,
has been a preliminary reason for supporting a voluntary model of labelling.
Biotechnology involves the use of complex technologies and it is difficult to reduce that
information clearly and truthfully in a label. In the event of a future dispute demanding
information to support one’s right to expression, the inability to clearly and truthfully
disseminate information about complex technologies involved in genetically modified
foods, could be used as a reason to favour a voluntary model of labelling and thereby limit
the freedom of expression in the Canadian Charter.

The voluntary labelling model adopted in Canada is regulated and monitored by Health
Canada. It requires labelling in the event of presence of allergens, sulphites or changes in
nutrition components. Health Canada states:
Currently in Canada, labelling is mandatory if there is a health or safety issue
with a food. For example, if the nutritional value or composition of the food
has been changed, or if there is an allergen present in the food, the food must
be labelled as such. In this situation, special labelling is required to alert
consumers or susceptible groups in the population. This applies to all foods,
including GM foods.343
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The above quote indicates a restricted voluntary labelling model being adopted in Canada.
The above restriction; however, are applicable to all food types whether GM or not and
hence there is no particular restriction applicable only to GM foods.

Biotechnology today has opened the doors for increased and enhanced production of food
through a variety of scientific tools and techniques. According to the CFIA there have
been three major consultations since 1993 in Canada on labelling of foods derived from
genetic engineering or modern bio-technology. A set of guidelines were developed based
on the below mentioned consensus:





Require mandatory labelling if there is a health or safety concern, i.e., from
allergens or a significant nutrient or compositional change (these decisions will be
made by Health Canada), in order to inform consumers of the allergen or change
Ensure labelling is understandable, truthful and not misleading
Permit voluntary positive labelling on the condition that the claim is not
misleading or deceptive and the claim itself is factual
Permit voluntary negative labelling on the condition that the claim is not
misleading or deceptive and the claim itself is factual.344

The underlying principle for labelling of GM foods is “Food products derived from
genetic modification that are demonstrated to be safe and nutritious, are treated the same
as non-genetically modified foods with regard to labelling requirements”.345

The voluntary labelling in Canada is based on the below two legislation and a guideline
(a)

The Food and Drugs Act and the Food and Drug Regulations346

(b)

The Consumer Packaging and Labelling Act347
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(c)

Voluntary Labelling and Advertising of Foods That Are and Are Not Products of

Genetic Engineering.348

5.3 (a) Food and Drugs Act
Section 5 and 6 of the Food and Drugs Act deals to a limited extent with labelling of food
in general. Section 5 states The Food and Drugs Act prescribes standards with labelling
and packaging and states:
(1) No person shall label, package, treat, process, sell or advertise any food
in a manner that is false, misleading or deceptive or is likely to create an
erroneous impression regarding its character, value, quantity, composition,
merit or safety.
(2) An article of food that is not labelled or packaged as required by, or is
labelled or packaged contrary to, the regulations shall be deemed to be
labelled or packaged contrary to subsection (1)349

This section requires labelling of all food including GM foods to be labelled in a truthful
manner without any mis-representation regarding its character, composition, safety, etc.
Further section 6 refers the same standard to be met with foods that are imported into
Canada or that has been sent from one province in to another.

Division 28 of the Food and Drug Regulations350 deals with Novel Foods. It elaborates the
definitions of “genetically modified’ and “novel foods”. It also states the procedure for
securing the approval from Health Canada with respect to safety. It requires all
information with respect to the method by which the novel food is manufactured,
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prepared, preserved, packaged and stored, details of the change, information on intended
use, information on history of use if available, text of labels to be used and the grounds on
which safe use is claimed. Health Canada has 45 days to review such application.351 The
Director could ask for additional information in which case an additional 90 days is
provided for review of information. After such a review a notice of acceptance or
rejection is given in writing.

Health Canada has developed “Guidelines for Safety Assessment of Novel food” which is
use to determine the safety of novel foods. This safety assessment process is based on
principles developed through international expert consultations carried out
by the World Health Organization (WHO) and the Food and Agriculture
Organization (FAO) of the United Nations, the Codex Alimentarius
Commission and the Organisation for Economic Co-operation and
Development (OECD).352
The scientific assessment of novel foods is based on scientific principles adopted by CAC.
Thus Health Canada has incorporated the CAC standards in it approval and regulation of
FDMB. As the texts in the Compilation were adopted prior to the adoption of the
Compilation, Canada has its policies for approval of FDMB in accordance with the
Compilation.

Canada recognises the rapid development in biotechnology and has made effects to update
scientific assessments with the advances in technology.353 In 1999, Canada setup
‘Canadian Biotechnology Advisory Committee’ that consists of experts from various
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disciplines and public. It provides advice on biotechnology with respect to ethical, social,
regulatory, economic and environmental and health issues. As an independent committee
it is tasked with proving neutral advice to federal departments and updating federal
departments with advances in biotechnology.354

5.3 (b) Consumer Packaging and Labelling Act
The Consumer Packaging and Labelling Act355 provides a uniform standard for labelling
all consumer goods. Section 2 of this act defines “label to be any mark, sign, device,
imprint, stamp, brand, ticket or tag”356. Section 10357 states that each label should contain
a declaration of net quantity, identity and principal place of the producer, identity of the
pre-packaged product in terms of its common or generic name or in terms of its function
and such information with respect to nature, quality, age, size, material, content, use or
method of manufacture or production of the pre-packaged product as may be described.
These requirements are in compliance with the Compilation. The Codex General Standard
for Labelling of Prepackaged Food358

prescribes similar conditions for labels in

international trade. However, the Consumer Packaging and Labelling Act also requires
producers to indicate content or method of production in terms of its common or generic
function or name and this could prove very challenging for bio-technology techniques.

The Consumer Packaging and Labelling Act also provides for appointment of inspectors
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under section 13 to enforce these provisions. The 2012 Canadian Budget states:

The Government will change how the Canadian Food Inspection Agency
(CFIA) monitors and enforces non-health and non-safety food labelling
regulations. The CFIA will introduce a web-based label verification tool that
encourages consumers to bring validated concerns directly to companies and
associations for resolution.359
With GM not considered as a safety issue, cutting costs for enforcement of consumer
labelling, monitoring positive or negative labelling of genetically modified ingredients in
food would prove even more challenging. This exacerbates the already complicated task
of verifying any labelling that is being used by producers. The Consumer Packaging and
Labelling Act prescribes a punishment in section 20(1)360 of a fine not exceeding $50,000
or imprisonment up to six months or both in a summary conviction and for a conviction
on indictment a fine not exceeding $250,000 or imprisonment of a term up to 2 years or
both. The section also provides for criminal liability of officers of corporations. It
prescribes a limitation period of two years.

5.3 (c ) National Standard on voluntary labelling and advertising of foods that are
and are not products of genetic engineering.

The last guideline that forms the foundation of all labelling of FDMB in Canada is the
National Standard on voluntary labelling and advertising of foods that are and are not
products of genetic engineering. According to this guideline genetic engineering refers to

359

Budget
2012,
(29
March
2012),
<http://www.budget.gc.ca/2012/plan/chap5-eng.html>
360
Supra note 11

online:

The

Government

of

Canada

138

Techniques by which the genetic material of an organism is changed in a
way that does not occur naturally by multiplication and/or natural
recombination. Examples of the techniques used in genetic engineering
include but are not limited to the following:
recombinant DNA (rDNA) techniques that use vector systems techniques
involving the direct introduction into the organism of hereditary materials
prepared outside the organism cell fusion (including protoplast fusion) or
hybridization techniques that overcome natural physiological, reproductive,
or recombination barriers, where the donor cells/protoplasts do not fall
within the same taxonomic family.361

It also defines a label as any legend, word or mark attached to, included in or on,
belonging to, or accompanying any food or package containing food. The Act further
elaborates the detailed requirements with respect to any claim about the ingredients of
food. The preliminary requirement for any claim is that it should be understandable,
informative, not false and not misleading. This requirement is similar to the Compilation,
the “General Guidelines on Claims”362 requires that claims should not be mis-leading,
should aim to provided consumers information and prohibits claims that cannot be
substantiated or that give rise to doubt about the safety of similar food or that could arouse
or exploit fear in the consumers.

The guidelines further details, the requirements for both positive and negative labelling. A
minimum of 5% of genetically modified content would be required to make a positive
claim. Section 5.1 deals with claims about a single ingredient, in order to be eligible under
this section more than 95% of the single ingredient food should be produced through
genetic engineering. For a multi-ingredient food, the claim would refer to individual
ingredients within the food not the food as a whole and it refers to those ingredients that
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make up 1% or more of the total weight of the food.363

Information regarding the

method of verification, origin of the external genetic material, technique of biotechnology used, reason for the use of bio-technology should be included in a label.364

Section 6 deals with negative labels; again the requirement for a negative label is that the
percentage of genetically modified content should be less than 5%. The condition being
that such genetically engineered ingredients should not have been intentionally added to
the food. Thus the food producer should intend to produce the food with 0% of GM
content.

The accommodation of 5% is provided given Canada’s support to the

development of genetically engineered food there could be unintended exposure that
could lead to mixing of GM ingredients. GM ingredients may inadvertently be included
due to “co-mingling as food passes through handling or storage systems, or if wind,
insects or animals have spread pollen or seed from one field to another.”365

The determination of the 5% limit has been considered appropriate for labelling as
Canada is amongst the leading producers of genetically engineered food. This standard is
periodically reviewed usually once in five years.366

Section 7 is an important section that deals with verification systems and testing. Section
7.1 states that verification methods may include and is not limited to testing, detection
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methods, inspection and audit tracking.367

Thus in this model of labelling, labels are

typically utilised when a manufacturer wishes to distinguish his product from
a competing product that consumer may perceive as inferior. The inferiority
may be related either to a particular trait such as an ingredient, quality, or to
a method of production, such as the use of pesticides. Voluntary labels thus
provide an important conduit to consumers because the information
conveyed may not be available through other means.368
The above quote indicates the difference in purpose of labelling, between the models of
labelling. In a mandatory model the purpose is inform the consumers irrespective of
whether the labelling will promote the product or not. In a voluntary labelling model;
however, the purpose is to inform the consumer with the ultimate intention of
distinguishing the product and promoting its sale.

5.4

Mandatory v Voluntary

A comparison of the European model of labelling to the Canadian model, indicates the
perceptual differences between the two models of labelling. This difference is bound to
continue given the uncertainty in determining the unintended effects of the long term use
of genetically modified food. Weighing the pro and cons of each model, merely highlights
the indeterminate nature of this problem.
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While the mandatory label model does provide for post market monitoring of unintended
effects, its preliminary objective of informing the consumers has not been fulfilled. The
language adopted in Europe has not informed the consumers of the exact nature of the
GM content. Labels that indicate whether the food is or is not GM will not adequately
assist consumers in differentiating among products, as the reason for genetic modification
has also been considered as relevant in determining consumer choice.369 The insufficiency
of the European labelling as a tool to provide such information to consumers was
highlighted in the Europeans and Biotechnology survey on 2010.370 Many are of the
opinion that mandatory labelling has only limited the choice of the consumers. It is
perceived as a warning to consumers and many have refrained from consuming
genetically modified food, as they are not aware of the exact nature of genetic
modification and its consequences.371

Voluntary labelling on the other hand has not provided any information to consumers. As
corporations are not required by law to label their products, producers will not label
unless they see a benefit in doing so.372 This leaves consumers with no information on the
basis of which they can choose the type of food they want to consume. The complicated
technology used in the process of genetic modification has compounded the problem. The
dissemination of any information with respect to the nature and consequences of genetic
modification without causing confusion and mistrust in the minds of consumers seems to
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be a perennial problem.

The heterogeneous labelling requirement in international trade has affected the costs of
food production. The tracing and labelling requirements followed in the EU have
increased the cost of productions. As the studies have indicated there is an increase in
costs whether significant or marginal will depend on parameters used in the survey. 373
Corporations would be required to adopt segregation and documentation techniques to be
able to authenticate food labels. The multitude of differences within the mandatory
labelling model has also added to the costs, as different procedures would be adopted
based on the threshold levels. In practise, “The mandatory labeling policies in the EU and
Japan have resulted in the virtual disappearance of any labelled GM product on the food
shelves. These policies encouraged food processors and retailers to avoid using GM
ingredients.”374 Hence, producers of FDMB have a restricted market available only in
countries supporting biotechnology. They are required to determine their market prior to
production of genetically modified food.

The choice between process based or product based labelling is another dimension that
has added to the existing problem of dissemination of information. The uncertainty over
determination of unintended effects of genetic modification supports the process based
labelling model. However, the mere indication that a food product has been produced
through genetic modification might not be sufficient information from a consumer’s
perspective. “It is potentially misleading to only provide for product labels, because, while foods
produced with GM materials (e.g., beer fermented using GM yeast) are not necessarily GM
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themselves, the fact that their production used GM materials is still important to some
consumers.”375 Thus it becomes necessary to determine the type of labelling based on the
characteristics of the product. This inability to provide for some generalisation has also
contributed to the rigid differences amongst countries on the model of labelling to be adopted.

The problem with verification has also been raised as a concern. The testing procedure
and the costs of testing has been a factor in determining the threshold level. The variation
in verification methods should also be considered prior to determining the threshold level.
In addition to different types of genetic modifications, there are different methods of
measuring the percentage of GM content.376 The wide variance in threshold levels between
the European Union and Canada indicates the policy choice based on a cost benefit
analysis between the cost and efficiency in verification and the ability to use labels that
would not misguide consumers.

The complex technology, the lack of certainty of unintended effects, social considerations,
variations within the two models of labelling, impact on trade and ability of labels to be
ineffective and misleading have all contributed towards the inability to effectively
determine the most effective model of labelling. The deliberations at the CAC brought
forth all these aspects. The Compilation adopted after nearly two decades of deliberations
provides a scientific basis for risk assessment, risk management and risk communication
of FDMB. The extent to which these principles will be adopted, implemented and updated
to accommodate advances in biotechnology will determine the effectiveness of the
Compilation.
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Chapter 6: Conclusion
The Labelling of FDMB has been pegged at the intersection of technology, politics,
religious, social and ethical beliefs, both at the national and international level. A number
of countries have adopted different labelling approaches for FDMB. Implementing a
labelling regime involves developing "a set of standards, actions to meet the standards,

certification of the actions, and governmental enforcement of the program.”377 The wide
variance in acceptance of FDMB has led to a complicated set of requirements that is
bound to increase with more countries adopting labelling standards and other countries
redefining existing standards.

The development of the standards has been the most controversial part of the process.
Based on the negotiations at the CAC, all countries seem to agree on the need to develop
some standards for labelling of food derived from modern biotechnology. However, the
exact nature of the standard and its implications in international food trade have been
issues in which no consensus could be achieved. The adoption of the Compilation last
year by the CAC has not altered the issues surrounding labelling of FDMB.

The

Compilation has; however, provided a more definite standard for evaluation of labelling
regimes.

The requirement that the approval and labelling standard should be based on sound
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scientific principles was first stated by WTO in its decisions dealing with the approval and
sale of FDMB or GM food. The Compilation has reiterated the same requirement. The
Compilation acknowledges that each country is free to adopt a model of labelling suitable
to its requirement, so long as it is based on scientific principles. As it has recognised
labelling as a tool of post market monitoring, the possibility of a blanket challenge before
the WTO that mandatory labelling amounts to a restrictive trade practise has been
restricted. However, this does not mean that the Compilation would completely protect
EU countries or other countries who adopt a mandatory labelling model from being
challenged. So long as the country requiring mandatory labelling is able to justify its need
for post market monitoring on a perceived risk of scientific certainty, a challenge at the
WTO will fail. Otherwise, the fact that such labelling could amount to a restrictive trade
practise could be upheld by the WTO.

The preliminary consideration in the event of a challenge could be whether FDMB are
considered as “like goods” to their conventional counterparts. The WTO so far has not
been clear on this issue. The Compilation has addressed this issue to a marginal extent by
declaring that FDMB are not necessarily different merely because of the means of
production. The lack of a definite answer only means a potential for possible claims. The
complexity in technology and wide possibility of unintended effects forces the issue to be
considered on a case by cases basis.

Thus even though the WTO is yet to consider a dispute directly on this issue, a review of
existing cases and the Compilation reveals that scientific justification would be the best
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ground for defence.

The other factors that the WTO could consider are consumer

preferences and political considerations. However, as these conditions are variable and
indeterminate, it would be hard to depend solely on such factors.

The Compilation; however, has provided countries with a common platform to launch
labelling legislation. The reiteration of the requirements in one document would
demystify the ambiguity in WTO interpretation. Given the nature of the problem and the
ideological differences, providing a common minimum understanding that regulation of
FDMB should be based on scientific evidence, is a definite step forward towards
harmonisation of international labelling requirements. Progress in this direction would
help promote international food trade and thus help achieve the purpose of the CAC.

At the national level however, a review of the current implementation of labelling
standards reveals that, labelling has not been able to address the problem it sought to
remedy. Neither model of labelling has been able to deliver the necessary information to
consumers or provide consumers a choice.378 The mandatory model that uses simple
labels to inform consumers have not been very successful as the information has been insufficient to impact consumer choice. The labels have acted as a warning and have forced
stores that used to sell FDMB to move away and switch to non-GM sources. This has
impacted the choice available to consumers in such markets. In the voluntary labelling
markets, companies do not label as they believe that costs will increase or they are unable
to reduce the information to a simple label without misleading consumers. The belief that
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consumers may not favour GM ingredients or the fact that other companies might not
follow due to the lack of labelling requirements and hence could lead to a loss in business
has prevent corporations from labelling. This has led to a lack of information to
consumers and has restricted their choice as many are not aware of what they are
consuming. Thus neither model of labelling has provided consumers sufficient
information to enable consumer choice.

The other problem at the national level that has now started gaining momentum in the EU
is the determination of threshold levels for negative labelling. Some countries such as
Canada have adopted one threshold; others however, feel the need to determine a separate
threshold for negative labelling. The recent adoption of standards in France and the
demand in United Kingdom379 to follow, indicates that another storm could be brewing.
The Compilation has not considered this aspect and has left it to the national governments
to decide. If the threshold for negative labelling varies from country to country it would
clearly add to the existing heterogeneity and complexity.

The issue of whether labelling should be product based or process based is again another
aspect in which there can be no safe generalisation. Some examples that indicate the
perplexities involved are as follows:
a single gene engineered into a tomato could hypothetically represent 1% of
the proteins expressed by the tomato plant. Does that fact make the entire
tomato GM? On the other hand, a beer produced using GM yeast could result
in a finished product with no GM protein content at all. Is that beer non-
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GM? Citrus are routinely grown using rootstock. The root of the plant is
from one variety, while most of the trunk and all of the branches are from
another variety. If the root is GM but the branches are not, are the oranges
GM?380

The labelling of the above products will depend on whether a country adopts a product or
a process labelling. Some countries such as the EU have both process and product based
labelling. Such an approach might be the safest as it would cover all foods exposed to or
containing GM ingredients. However, even with the adoption of both product and process,
the earlier problems of informing the consumers would still not be addressed.

Thus labelling of FDMB is a multi-dimensional problem which cannot be addressed by a
single strategy. Until science provides more definitive answers we might be stuck with a
multitude of conflicting requirements. The very nature of food and the fast pace of the
technology involved makes generalisation almost unproductive. More needs to be done to
educate consumers. The consumer information strategies (other than labelling) adopted in
the EU could be an example. The most suitable method for the co-existence of FDMB
and protection of consumer interests would be to educate consumers about the regulatory
process and the extensive scientific tests undertaken prior to release of the FDMB into the
market. The recent approval in Canada of “Genuity SmartStax” containing eight
genetically modified traits without any public disclosure about how it was approved 381 is
not a method that would get consumer support and loyalty. Further, integrative testing
should be adopted in which all aspects of FDMB are considered simultaneously. Such
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testing should be adopted in a transparent manner.382 The Canadian Biotechnology
Advisory Committee, that has been tasked with providing information to the public, needs
needs to increase its efforts to make unbiased information more accessible to consumers.
Increased access to information would help build confidence in biotechnology
development and would channel the growth of biotechnology to the needs of consumers.

Investing in unbiased consumer education and approaching FDMB with extensive
integrated testing would help achieve and sustain consumer support for FDBM. Labelling
of FDMB could be considered subsequent to extensive education. Only if consumers are
aware of the exact nature of genetic modification will they be able to make an informed
choice and in such an educated market, producers would also be willing to adopt
labelling.
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Appendix I
Procedures for the Elaboration of Codex Standards and Related Texts
Note: Throughout this text the word “Standard” is meant to include any of the
recommendations of the Commission intended to be submitted to Governments for
acceptance. Except for provisions relating to acceptance, the Procedures apply mutatis
mutandis to codes of practice and other texts of an advisory nature.
1. The full procedure for the elaboration of Codex standards is as follows. The
Commission decides, taking into account the “Criteria for the Establishment of Work
Priorities”, that a standard should be elaborated and also which subsidiary body or other
body should undertake the work. Decisions to elaborate standards may also be taken by
subsidiary bodies of the Commission in accordance with the above-mentioned criteria
subject to subsequent approval by the Commission or its Executive Committee at the
earliest possible opportunity. The Secretariat arranges for the preparation of a “proposed
draft standard” which is circulated to governments for comments and is then considered in
the light of these by the subsidiary body concerned which may present the text to the
Commission as a “draft standard”. If the Commission adopts the “draft standard” it is sent
to governments for further comments and in the light of these and after further
consideration by the subsidiary body concerned, the Commission reconsiders the draft and
may adopt it as a “Codex standard”. The procedure is described in Part 1 of this
document.
2. The Commission or the Executive Committee, or any subsidiary body, subject to the
confirmation of the Commission or the Executive Committee may decide that the urgency
of elaborating a Codex standard is such that an accelerated elaboration procedure should
be followed. While taking this decision, all appropriate matters shall be taken into
consideration, including the likelihood of new scientific information becoming available
in the immediate future. The accelerated elaboration procedure is described in Part 2 of
this document.
3. The Commission or the subsidiary body or other body concerned may decide that the
draft be returned for further work at any appropriate previous Step in the Procedure. The
Commission may also decide that the draft be held at Step 8.
4. The Commission may authorize, on the basis of two-thirds majority of votes cast, the
omission of Steps 6 and 7, where such an omission is recommended by the Codex
Committee entrusted with the elaboration of the draft. Recommendations to omit steps
shall be notified to Members and interested international organizations as soon as possible
after the session of the Codex Committee concerned. When formulating recommendations
to omit Steps 6 and 7, Codex Committees shall take all appropriate matters into
consideration, including the need for urgency, and the likelihood of new scientific
information becoming available in the immediate future.
5. The Commission may at any stage in the elaboration of a standard entrust any of the
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remaining Steps to a Codex Committee or other body different from that to which it was
previously entrusted.
6. It will be for the Commission itself to keep under review the revision of “Codex
standards”. The procedure for revision should, mutatis mutandis, be that laid down for the
elaboration of Codex standards, except that the Commission may decide to omit any other
step or steps of that Procedure where, in its opinion, an amendment proposed by a Codex
Committee is either of an editorial nature or of a substantive nature but consequential to
provisions in similar standards adopted by the Commission at Step 8.
7. Codex standards are published and governments are invited to notify the Commission’s
Secretariat of the status or use of the Codex standard in accordance with their established
legal and administrative procedures. They are also sent to international organizations to
which competence in the matter has been transferred by their Member States. See Part 3
of this document. Details of notifications are published periodically by the Commission’s
Secretariat.
PART 1: UNIFORM PROCEDURE FOR THE ELABORATION OF CODEX
STANDARDS AND RELATED TEXTS
Steps 1, 2 and 3
(1) The Commission decides, taking into account the “Criteria for the Establishment of
Work Priorities”, to elaborate a World-wide Codex Standard and also decides which
subsidiary body or other body should undertake the work. A decision to elaborate a
World-wide Codex Standard may also be taken by subsidiary bodies of the Commission
in accordance with the above mentioned criteria, subject to subsequent approval by the
Commission or its Executive Committee at the earliest possible opportunity. In the case of
Codex Regional Standards, the Commission shall base its decision on the proposal of the
majority of Members belonging to a given region or group of countries submitted at a
session of the Codex Alimentarius Commission.
(2) The Secretariat arranges for the preparation of a proposed draft standard. In the case of
Maximum Limits for Residues of Pesticides or Veterinary Drugs, the Secretariat
distributes the recommendations for maximum limits, when available from the Joint
Meetings of the FAO Panel of Experts on Pesticide Residues in Food and the
Environment and the WHO Core Assessment Group on Pesticide Residues (JMPR), or the
Joint FAO/WHO Expert Committee on Food Additives (JECFA). In the cases of milk and
milk products or individual standards for cheeses, the Secretariat distributes the
recommendations of the International Dairy Federation (IDF).
(3) The proposed draft standard is sent to Members of the Commission and interested
international organizations for comment on all aspects including possible implications of
the proposed draft standard for their economic interests.
Step 4
The comments received are sent by the Secretariat to the subsidiary body or other body
concerned which has the power to consider such comments and to amend the proposed
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draft standard.
Step 5
The proposed draft standard is submitted through the Secretariat to the Commission or to
the Executive Committee with a view to its adoption as a draft standard. (Without
prejudice to any decision that may be taken by the Commission at Step 5, the proposed
draft standard may be sent by the Secretariat for government comments prior to its
consideration at Step 5, when, in the opinion of the subsidiary body or other body
concerned, the time between the relevant session of the Commission and the subsequent
session of the subsidiary body or other body concerned requires such action in order to
advance the work). In taking any decision at this step, the Commission or the Executive
Committee will give due consideration to any comments that may be submitted by any of
its Members regarding the implications which the proposed draft standard or any
provisions thereof may have for their economic interests. In the case of Regional
Standards, all Members of the Commission may present their comments, take part in the
debate and propose amendments, but only the majority of the Members of the region or
group of countries concerned attending the session can decide to amend or adopt the draft.
In taking any decisions at this step, the Members of the region or group of countries
concerned will give due consideration to any comments that may be submitted by any of
the Members of the Commission regarding the implications which the proposed draft
standard or any provisions thereof may have for their economic interests.
Step 6
The draft standard is sent by the Secretariat to all Members and interested international
organizations for comment on all aspects, including possible implications of the draft
standard for their economic interests.

Step 7
The comments received are sent by the Secretariat to the subsidiary body or other body
concerned, which has the power to consider such comments and amend the draft standard.
Step 8
The draft standard is submitted through the Secretariat to the Commission together with
any written proposals received from Members and interested international organizations
for amendments at Step 8 with a view to its adoption as a Codex standard. In the case of
Regional standards, all Members and interested international organizations may present
their comments, take part in the debate and propose amendments but only the majority of
Members of the region or group of countries concerned attending the session can decide
to amend and adopt the draft.
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Appendix II
Rule XI of the Rules of Procedure of the Codex Alimentarius Commission:
1. The Commission may establish the following types of subsidiary bodies:
(a) subsidiary bodies which it deems necessary for the accomplishment of its work in the
finalization of draft standards;
(b) subsidiary bodies in the form of:
(i) Codex Committees for the preparation of draft standards for submission to the
Commission, whether intended for worldwide use, for a given region or for a group of
countries specifically enumerated by the Commission.
(ii) Coordinating Committees for regions or groups of countries which shall exercise
general coordination in the preparation of standards relating to such regions or groups of
countries and such other functions as may be entrusted to them.
2. Subject to paragraph 3 below, membership in these subsidiary bodies shall consist, as
may be determined by the Commission, either of such Members of the Commission as
have notified the Directors-General of FAO or WHO of their desire to be considered as
Members thereof, or of selected Members designated by the Commission.
3. Membership of subsidiary bodies established under Rule XI.1(b)(i) for the preparation
of draft standards intended primarily for a region or group of countries, shall be open
only to Members of the Commission belonging to such a region or group of countries.
4. Representatives of members of subsidiary bodies shall, insofar as possible, serve in a
continuing capacity and shall be specialists active in the fields of the respective subsidiary
bodies.
5. Subsidiary bodies may only be established by the Commission except where otherwise
provided in these Rules. Their terms of reference and reporting procedures shall be
determined by the Commission.
6. Sessions of subsidiary bodies shall be convened by the DirectorsGeneral of FAO and
WHO:
(a) in the case of bodies established under Rule XI.1(a), in consultation with the
Chairperson of the Commission;
(b) in the case of bodies established under Rule XI.1(b)(i) (Codex Committees), in
consultation with the chairperson of the respective Codex Committee and also, in the case
of Codex Committees for the preparation of draft standards for a given region or group of
countries, with the Coordinator, if a Coordinator has been appointed for the region or
group of countries concerned;
(c) in the case of bodies established under Rule XI.1(b)(ii) (Coordinating Committees), in
consultation with the Chairperson of the Coordinating Committee.
7. The Directors-General of FAO and WHO shall determine the place of meeting of
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bodies established under Rule XI.1(a) and Rule XI.1(b)(ii) after consultation, where
appropriate, with the host country concerned and, in the case of bodies established under
Rule XI.1(b)(ii), after consultation with the Coordinator for the region or group of
countries concerned, if any.
8. Notice of the date and place of each session of bodies established under Rule XI.1(a)
shall be communicated to all Members of the Commission at least two months before the
session.
9. The establishment of subsidiary bodies under Rule XI.1(a) and Rule XI.1(b)(ii) shall be
subject to the availability of the necessary funds, as shall the establishment of subsidiary
bodies under Rule XI.1(b)(i) when any of their expenses are proposed to be recognized as
operating expenses within the budget of the Commission in accordance with Article 10 of
the Statutes of the Commission. Before taking any decision involving expenditure in
connection with the establishment of such subsidiary bodies, the Commission shall have
before it a report from the Director-General of FAO and/or WHO, as appropriate, on the
administrative and financial implications thereof.
10. The Members who shall be responsible for appointing Chairpersons of subsidiary
bodies established under Rule XI.1(b)(i) shall be designated at each session by the
Commission and shall be eligible for re-designation. All other officers of subsidiary
bodies shall be elected by the body concerned and shall be eligible for re-election.
11. The Rules of Procedure of the Commission shall apply mutatis mutandis to its
subsidiary bodies.”
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Appendix III

Compilation of Codex Texts Relevant to Labelling of Food Derived from
Modern Biotechnology *
CAC/GL 76-2011
1. PURPOSE
The purpose of this document is only to recall and assemble in a single document some
important elements of guidance from Codex texts, which are relevant to labelling of foods
derived from modern biotechnology.
2. CONSIDERATIONS
Different approaches regarding labelling of foods derived from modern biotechnology are
used. Any approach implemented by Codex members should be consistent with already
adopted Codex provisions. This document is not intended to suggest or imply that foods
derived from modern biotechnology are necessarily different from other foods simply due
to their method of production.
3. COMPILATION OF RELEVANT CODEX TEXTS
3.1 General Standard for the Labelling of Prepackaged Foods, (Codex Stan 1-1985); and
particularly, Sections 3.1, 3.2, 4.1.1, 4.1.2, 4.2.2, 7.1
3.2 General Guidelines on Claims (CAC/GL 1-1979); and particularly, Sections 1.2, 1.3,
Section 2 – Definition of Claim, 3.3, 3.5, 4.1, 5.1 (iii), 5.1 (iv), 5.1 (v), 5.1 (vi)
3.3 Guidelines for Use of Nutrition and Health Claims (CAC/GL 23-1997); Introduction
and particularly, Sections 1.1, 1.2, 1.3, 1.4 y 1.5
3.4 Guidelines for the Production, Processing, Labelling and Marketing of Organically
Produced Foods (CAC/GL 32-1999); and particularly Section1.5
3.5 General Guidelines for Use of the Term “Halal” (CAC/GL 24-1997)
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